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Abstract

Brain functions, such as learning, orchestrating locomotion, memory recall, and
processing information, all require glucose as a source of energy. During these functions,
the glucose concentration decreases as the glucose is being consumed by brain cells. By
measuring this drop in concentration, it is possible to determine which parts of the brain
are used during specific functions and consequently, how much energy the brain requires
to complete the function. One way to measure in vivo brain glucose levels is with a
microdialysis probe. The drawback of this analytical procedure, as with many steadystate fluid flow systems, is that the probe fluid will not reach equilibrium with the brain
fluid. Therefore, brain concentration is inferred by taking samples at multiple inlet
glucose concentrations and finding a point of convergence. The goal of this thesis is to
create a three-dimensional, time-dependent, finite element representation of the brainprobe system in COMSOL 4.2 that describes the diffusion and convection of glucose.
Once validated with experimental results, this model can then be used to test parameters
that experiments cannot access. When simulations were run using published values for
physical constants (i.e. diffusivities, density and viscosity), the resulting glucose model
concentrations were within the error of the experimental data. This verifies that the
model is an accurate representation of the physical system.

xii
In addition to accurately describing the experimental brain-probe system, the
model I created is able to show the validity of zero-net-flux for a given experiment. A
useful discovery is that the slope of the zero-net-flux line is dependent on perfusate flow
rate and diffusion coefficients, but it is independent of brain glucose concentrations. The
model was simplified with the realization that the perfusate is at thermal equilibrium with
the brain throughout the active region of the probe. This allowed for the assumption that
all model parameters are temperature independent. The time to steady-state for the probe
is approximately one minute. However, the signal degrades in the exit tubing due to
Taylor dispersion, on the order of two minutes for two meters of tubing. Given an
analytical instrument requiring a five μL aliquot, the smallest brain process measurable
for this system is 13 minutes.

1
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Introduction

Brain functions, such as learning, orchestrating locomotion, recalling memory,
coping with stress and processing information, all require glucose as a source of energy. 1
During these functions, there are localized drops in glucose concentration in the areas of
the brain being used. By measuring the drop in glucose concentration, it is possible to
determine which parts of the brain are used during specific functions and consequently,
how much energy the brain requires to complete that function. One way to measure
glucose levels in the brain is with a microdialysis probe. Most recently, microdialysis has
been used to study animal behavior, seizures, insulin-induced hypoglycemia,
transplantations, neurotransmitters and pharmacology. 2,3
A microdialysis probe is essentially a needle with a semipermeable membrane
covering the tip. When the probe is inserted into the brain, a fluid almost identical to
brain fluid, known as the perfusate, is perfused though the probe. The perfusate enters
the probe at the top and flows down the center. It then passes through two small bore
holes near the base of the probe into the outer annulus, which is the active region. The
fluid also exits the probe at the top. The only difference between the brain fluid and the
perfusate is the concentration of glucose. This creates a concentration gradient across the
membrane, and glucose diffuses from the fluid of higher concentration to the fluid of

2
lower concentration to reduce the gradient. Figure 1 shows the case in which the
concentration of glucose in the perfusate is less than that of the brain.

From reservoir

To analyzer

Diffusion of
glucose
Fluid
flow

Membrane

Brain
space

Figure 1. Schematic of brain-probe system.

The drawback of this analytical procedure, as with many steady-state fluid flow
systems, is that the perfusate will exit the probe before it can reach chemical equilibrium
with the brain fluid. Therefore, brain concentration is inferred by taking samples at
multiple inlet glucose concentrations and finding a point of convergence. This is called
the Zero-Net-Flux (ZNF) method because the brain concentration is calculated by
realizing there is no net flux of glucose when the perfusate is at equilibrium with the
brain fluid. 4

3
A two-dimensional, axisymmetric finite element representation of a microdialysis
brain-probe system was created in COMSOL 4.2. This model accurately describes the
diffusion and convection of glucose in the brain-probe system. The overall goal was to
use this model to validate assumptions made in the analysis of experimental results. 5

4

2

Hypothesis

In the proposed work, I tested the following two hypotheses:

Current assumptions made in analyzing microdialysis data using ZNF are
accurate.
Application of the ZNF method rests on several assumptions that are not
experimentally assessable in vivo. I believe that by creating a three-dimensional finite
element model of the brain-probe system I can validate all assumptions made using ZNF.
I also believe that the wait time between microdialysis trails is less than 15 minutes,
which is the current standard.
With a working model I can test other experimental areas previously inaccessible
such as temperature dependence, parameter sensitivity and reverse microdialysis.

5
Dilution of signal concentration in the outlet perfusate tubing is the limiting
factor in temporal resolution.
The microdialysis probe is only between two to four millimeters in length, but is
followed by up to two meters of tubing before samples are collected. It is possible that
Taylor dispersion significantly reduces the difference between nominal brain
concentration and the concentration during an observed brain process. This is another
area that is accessible by model but not in vivo.

6

3

Background

In order to understand how to create an accurate model, it is necessary to have an
understanding of dialysis, mass transport and basic brain physiology. In the following
sections, some of the basics of these concepts are described.

3.1

Motivation

One of the major fields of study in neurology today is the connection between
glucose concentration in the brain and brain functions, such as learning and
memorization.4 The problem that neurologists face is that brain glucose concentration
cannot be measured directly. In the search for an indirect form of brain measurements,
the method of microdialysis was developed. ZNF is one method used for calibrating
output measurements to actual brain concentrations.4
When using ZNF, neurologists perfuse a microdialysis probe with a range of
different glucose concentrations and record the outlet concentration. When the net
change in glucose concentration through the probe is plotted against inlet concentration, a
linear trend is observed. The point at which the line of best fit crosses the x-axis is the
concentration of glucose in the brain, because it is at this point that there is not flux
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across the probe, i.e. no concentration gradient. This concept is shown graphically in
Figure 2.

Figure 2. Zero net flux. Probe is perfused at multiple analyte
concentrations (Cin, x-axis) and plotted against net flux of analyte across
the membrane (Cout-Cin, y-axis). If ZNF is valid, the points can be fit by
a line and the x-intercept is brain concentration.

In theory, ZNF is a reliable and efficient means of measuring brain concentration.
However, the ZNF method is based on certain important transport assumptions which
cannot be demonstrated experimentally due to the complexity of a living system.
By modeling the brain-probe system using finite element analysis, it will be
possible to define all of the system’s unknown parameters. If the model accurately
predicts experimental results, then it may be inferred that ZNF assumptions are
reasonable and measurements gained from ZNF readings can be assumed to be accurate.
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3.2

Microdialysis

3.2.1

History

Microdialysis was first developed in the 1960s to characterize interstitial water in
dog brains. One of the earliest units was a dialysis sac, in which a membrane was placed
in the brain and allowed to sit for an extended period of time. It was assumed that by the
time the sac was removed, the contents had come to equilibrium with the extracellular
fluid (ECF) in the brain. 6 In 1972, Delgado and Defeudis first reported the use of a probe
and technique that caused significantly less tissue disruption than in previous studies. 7
The next breakthrough in microdialysis came in 1974 when Ungerstedt and Pycock
reported using “hollow fibers” to infer ECF concentrations. The hollow fibers were
tubular semipermeable membranes measuring 200-300 μm in diameter. 8 Today, the most
widely-used probe is a needle with membrane covering only the tip of the unit. 9
Within the category of membrane needle microdialysis, there are four main probe
configurations (Figure 3). 10 In a transversal probe, the inlet and outlet streams are on
opposite sides of the membrane. This geometry is used mostly for measuring superficial
brain structures. Loop, side-by-side, and concentric geometries are in a category of
microdialysis called vertical probes. Vertical probes are most commonly used in research
today; selecting one over the other comes down to preference. 11

9

Figure 3. Basic geometry for four common microdialysis designs. (A)
transversal, (B) loop, (C) side-by-side and (D) concentric.10

The majority of microdialysis probes are made of stainless steel or fused silica
tubing with a 1 to 4 mm length of semipermeable membrane at the tip. Probes can either
be implanted permanently or inserted temporarily into tissue or bone using a permanent
guide cannula.10

3.2.2

Microdialysis Probe Used in This Project

In this project, a CMA 12 microdialysis probe (Figure 4) was modeled. This
specific probe used has a concentric geometry with a stainless steel casing and a 3 mm
length of 20 kDa cutoff polycarbonate membrane at the tip.5 While CMA reports
membrane thickness to be 25 μm, many experiments have reported swelling of the
membrane in situ. Rosenbloom et al. reported a membrane thickness of 40 μm using a
scanning electron microscope (SEM). 12
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Figure 4. CMA 12 microdialysis probe 13

3.3

Brain Physiology

While it is not within the scope of this thesis to fully explore the physiology of the
brain, it is imperative to have a general grasp of related topics such as brain structure and
metabolic supply. 14
Brain cells produce energy necessary for functioning by metabolizing glucose
found in the ECF; sufficient oxygen is needed for cells to utilize their most efficient
metabolic pathway. 15 Glucose is carried from the stomach to the brain in the blood
stream and is transported to brain tissue via capillaries. Figure 5 is a simple diagram of
the brain-probe system in which the center rectangle is the probe.2 The brain itself is
composed mostly of neurons (white circles) and glial cells (black circles). 16 Glial cells
provide structure for neurons and help regulate molecules available to neurons in the
ECF. 17

11
50 μm

Figure 5. Diffusion of glucose (arrows) from the capillaries (red lines) to
the probe (central rectangle). The white circles represent neurons and the
black circles represent glial cells.2

The transport of glucose (arrows) from the capillaries (red lines) to the probe is
impeded by the brain cells. As can be seen in Figure 5, glucose has to physically travel
around the cells, which increases the length of the diffusion pathway. However, these
cells cannot simply be considered as physical diffusion inhibitors, as neuron and glial
cells are constantly consuming glucose. The amount of glucose consumed by the cells is
dependent on the current neurological activity.2
Capillaries, on average, are equally spaced and evenly distributed throughout the
brain. Due to the relative rates of oxygen diffusion and consumption in the brain, oxygen
is almost entirely consumed by the time it reaches any distance 25 µm from the capillary.
Because no cell could survive outside of 25 µm from a capillary, capillaries are always
found within 50 µm of each other in healthy or normal brain tissue.14
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3.4

Transport of Glucose

3.4.1

Transport model for Probe-Brain System

The transport of glucose in the brain-probe system is based on two governing
differential equations: Navier-Stokes (Equation 1) and the conservation of mass
(Equation 4).
�⃗
𝜕𝑣

𝜌 � 𝜕𝑡 + 𝑣⃗ ∙ ∇𝑣⃗� = −∇𝑝 + 𝜇∇2 𝑣⃗ + 𝑓

(1)

Navier-Stokes models the motion of a fluid and works best with laminar flow
(Re<2000). The first term represents the unsteady-state acceleration of the flow while the
second term is convective acceleration. The third and fourth terms represent the pressure
gradient and stress, respectively. The fifth encompasses external forces such as gravity
and electromagnetism; these forces can be assumed to be negligible in the small brainprobe system. Navier-Stokes is used to model only the flow of the perfusate, as there is
no bulk flow in the membrane and brain.
For the given microdialysis unit, the Reynolds number
𝑅𝑒 =

𝜌𝑤𝑎 𝑣
𝜇

(2)

is on the order of 0.02, which qualifies it for Stoke’s (or creeping) flow (Re«1). 18 In
creep flow, the inertial terms are negligible, which allows for a much simpler differential
equation
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�⃗
𝑑𝑣

𝜌 𝑑𝑡 = −∇𝑝 + 𝜇∇2 𝑣⃗.

(3)

Equation 3 will be used to describe the flow of perfusate through the microdialysis
probe.18
The conservation of mass equation
𝑑𝑐
𝑑𝑡

+ ∇ ∙ (𝐷∇𝑐) = −𝑣⃗ ∙ ∇𝑐

(4)

describes the transport of material by both convection and diffusion. It will be used to
simulate the diffusion of glucose from the brain, through the membrane, and into the
perfusate, as well as the convection of the glucose within the perfusate. The first term
represents the unsteady-state change in concentration. The second term represents the
diffusion due to a concentration gradient, while the third term represents the transport due
to convection.
Equation 4 is only accurate if Fickian diffusion applies to this system. Fickian
diffusion assumes that diffusion is independent of the magnitude of the concentration and
that there is no bulk flow of material in the brain and through the membrane. At the
dilute concentrations used in this thesis, diffusion is dependent solely on the
concentration gradient, not the magnitude of the concentration. Bulk flow through the
pores of the membrane could occur for two reasons, extremely high concentration or
pressure gradients. If the concentration gradient is too large, and diffusion therefore too
fast, the glucose can actually pull water along with it through the membrane and create
bulk flow. The concentration gradients in this thesis are not large enough to induce bulk
flow. If the aECF is not identical to the brain composition, other ions may diffuse across
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the membrane as well. However, as long as these gradients are kept small, the diffusion
of glucose will be independent from the diffusion of other components.
If the pressure gradient across the membrane is too large water will be forced
through the probe. The minimum pressure in the probe needed to induce flow is 6.2 kPa;
this is based on the radius and length of exit tubing connecting the probe and the
analytical instrument.18 Normal blood pressure in a rat brain is 17.2 kPa. 19 This
difference is not large enough to induce bulk flow of water.
The biggest, most consequential assumption made in this model is that the system
can be described using continuum mechanics. Continuum mechanics is the analysis of
materials modeled as a continuous material rather than as discrete particles. It is the
assumption that this model is describing the system on a scale large enough to consider
behaviors of and interactions between individual molecules negligible compared to the
behavior of the material as a whole. Equations 1-4 are only valid in the field of
continuum mechanics. Above, the brain is described as a non-homogonous, noncontinuous material. Later this description will be adjusted in order to approximate the
brain as a continuous material for use in modeling.
Boundary and initial conditions for Equations 3 and 4 are defined in Appendix A.

3.4.2

Transport Model for Post-Probe Tubing

In addition to modeling the transport of glucose from the brain to the perfusate,
the transport of glucose from the probe to the detector was also modeled. When
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conducting in vivo microdialysis, it is imperative to create an environment free from
stress for the rat specimens. To achieve this, the rats need to be able to move around
freely within an area, unhampered by testing equipment. For this to happen, the tubing
that delivers the perfusate from the probe to the glucose detector must be of considerable
length. With glucose traveling in creep flow and tubing of up to two meters in length,
perfusate can take as long as an hour to reach the detector. 20 As perfusate flows down the
tubing, glucose is diffusing both radially and linearly. If the tubing is too long or the
flow rate is too small, signal strength will degrade due to Taylor dispersion. If too much
dispersion occurs, the signal will be indistinguishable from nominal concentration and
will therefore be undetectable. The minimum signal duration (i.e. time of thought) that
can be detected by an analytical instrument will therefore be determined.

3.5

Prior Work

Due to the many uses microdialysis has in a variety of fields, it has been studied
and approached both theoretically and numerically in many previous works. While this
model draws on previous work, the work shown here adds further insight and
development to the field of microdialysis. 21
Lindefors and Amberg crafted a massively complex and mechanistic function that
is based on in vitro data and detailed system parameters. 22 The function is theoretically
sound, but is too detailed for repeated use. A simple and quick model based on first
principles and easily determined in vivo parameters was able to be created.
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3.5.1

Calibrating In Vitro

The first attempts at characterizing outlet concentrations were geared towards
correlating a calibration between in vitro and in vivo measurements. This approach
assumed that the transport of glucose from a non-stirred beaker solution to the probe
would be the same as the transport from the brain to the probe, or at least that a simple
relationship existed between them. 23 Zetterström et al. quickly realized that the brain is
significantly more complex than a solution in a beaker and that in vivo measurements
could not be inferred from in vitro data.
Benveniste attempted to amend Zetterström’s equations to fit empirical data.2
However, Benveniste was only able to accurately represent a few substances, mainly
ions. When Benveniste tried to account for molecules involved in uptake mechanisms,
errors in the calculations increased. For this reason, this model describes an in vivo
system. The brain is simplified to facilitate continuum mechanics; the model still reflects
the real system close enough to produce accurate results. While Benveniste and
Zetterström modeled probes of the loop design (Figure 3.B), this model describes a probe
with a concentric geometry (Figure 3.D).

3.5.2

Flow Rate Based Models

An alternative approach to zero-net-flux is zero flow. In 1985, Jacobson et al.
proposed a method based on the principal of zero flow dialysis. 24 This technique
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involves a membrane sac filled with aECF (artificial extracellular fluid) being placed in
the brain for an extended period of time, allowing the aECF to reach equilibrium with the
brain.6 Jacobson used needle probes and recorded outlet concentrations at a variety of
flow rates. He then extrapolated this data back to a flow rate of zero. The problem with
this approach is the concentration has an exponential term, and therefore asymptotic,
profile as the flow rate approaches zero. The ZNF system and this model are based on
well-defined, linear interpolation as opposed to sensitive, asymptotic extrapolation.
Jacobson’s model is based on the geometry of a simple annulus.
Bungay et al. furthered Jacobson’s work and, in doing so, developed the first
model to incorporate active biological processes. 25 Unfortunately, Bungay’s model is too
detailed and requires knowledge of parameters that cannot be determined experimentally.
The model is therefore based on assumptions and estimated parameters.

3.5.3

Numerical Models

As computing power increases and becomes more accessible, researchers are
turning to numerical modeling to describe the microdialysis systems. Norton et al. and
Wang et al. both used a modeling program called COMSOL to describe the probe. 26,27
However, both models only described the probe in vitro. This paper will present the first
numerical model of an in vivo microdialysis system. As with Jacobson, Norton’s model
is designed around an annular geometry, while Wang described a side-by-side probe
(Figure 3.C).
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4

Materials and Methods

4.1

Finite Element Method

The finite element method (FEM) was born out of the need for accurate and
efficient approximate solutions. First popularized in the 1960s, FEM was used to study
stresses in complex aircraft structures. 28 Since then, the simplicity and effectiveness of
FEM has allowed it to spread to every aspect of continuum mechanics.
In a continuum mechanics problem, such as diffusion of glucose through a
membrane, the domain is made up of an infinite number of values, and therefore the
problem has an infinite number of unknowns.28 FEM is essentially the breaking up of a
single complex differential system into many simpler problems. 29 The overall solution
domain is segmented into smaller subdomains called finite elements. 30 Each element is
assumed to be solvable using a simple function that can accurately approximate the real
system. These approximate solutions are called trial functions.31 Each element has a
number of nodes on their boundary which act as local boundary conditions. By
connecting a finite number of elements, defined by nodes and internally approximated by
trial functions, a highly complex system can be easily and efficiently approximated with
reasonable accuracy.28
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A good way to visualize FEM is by considering a simplified system, such as the
linear transfer of heat through a metal rod.30 The temperature profile in Figure 6 could
easily be modeled by a third order function, but for the sake of the example, assume no
exact solution can be found. The first step of FEM is to break the domain into
subdomains and create what is called a mesh, as in Figure 7. In this example, the rod is
divided into two subdomains, with a boundary across the middle of the rod. As can be
seen, each element can now be approximated by a parabolic equation (T=a1+a2x+a3x2). If
there are two parabolic equations, with two unknown constants each, there are four
unknowns. In FEM, these four constants are iterated until boundary conditions are met
and the approximation of the temperature profile is within a set tolerance.

Figure 6. Temperature profile down the length of a metal rod.
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Figure 7. Temperature profile down the length of a metal rod discretized
into two finite elements.

The first major decision that needs to be made is selecting the mesh, or deciding
how to break up the system and is covered below. Once an appropriate mesh has been
selected, a trial function has to be selected. Trial functions are usually polynomials
because they are easy to integrate and differentiate.28 The order of the polynomial is
dependent on the number of parameters being solved for and the number of nodes on an
element.
2(𝑗−1) (1
𝑦𝑎 = 𝑦𝑜 (𝑥) + ∑𝑁
− 𝑥2)
𝑗=1 𝑎𝑗 𝑥

(5)

is a commonly used trial function, especially for profiles of symmetric shape. 31
Next, the governing differential equation is set equal to zero and inserted into
Equation 5. If Equation 5 is the analytical solution to the problem, then inserting it into
the governing differential equation will produce a value of zero. However, if Equation 5
is only an approximate solution, which is usually the case, then a value will be produced
that is dependent on x. This value is called the residual and is represented by Rerr.28
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From this point onward, the coefficients aj would be continually adjusted until the
residual is within an allowable tolerance. However, in the residual’s current state, the
value is dependent on the location in the system it is being sampled; therefore,
comparison between residuals would be difficult. It is therefore necessary to average the
residual function. One way to carry this out is to take the inner product of the trial
function with another function, called the test function.28 The selection of the test
function is as important as selecting the trial function as it dictates which form of the trial
function is most accurate. Many methods have been derived to select appropriate test
functions, the most notable being collocation, subdomain, least squares, moment, and
Galerkin.28
As the Galerkin method is the most commonly used method in fluid mechanics
and diffusion problems, it will be the focus of this background. In this method, the test
function is selected from the same family of functions as the trial function. In the case of
Equation 5, a reasonable test function would be

𝑤𝑘 = (1 − 𝑥 2 ).

(6)

To find the inner product of two functions, they are simply multiplied and then
integrated over the domain, as in

+𝑥

(𝑅𝑒𝑟𝑟 , 𝑤𝑘 ) = ∫−𝑥 𝑅𝑤𝑘 𝑑𝑥.

(7)
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Now sets of coefficients can be easily compared using the residual and the trial
function can be optimized. Once an accurate trial function has been established for each
finite element, the elements can be put back together to form a cohesive single solution
domain. For efficiency purposes, COMSOL will be used to do the computing.

4.2

System Parameters and Boundary Conditions

In reality, the path of diffusion of glucose from a blood vessel to a probe is
impeded both physically and chemically by brain cells. Not all of the glucose that leaves
the blood vessel makes it to the probe; some of the glucose is absorbed by brain cells.
The glucose that does make it to the probe does not diffuse there in a straight line; it has
to move around the brain cells (Figure 5). The diffusion path is thus influenced by
tortuosity (λ). The more tortuous the paths in a material are, the longer a molecule’s path
is to travel from one point to another. To accurately approximate the brain as a
continuous material, all of these factors can be combined with the constant of free
diffusion of glucose in ECF (DECF) to produce an effective diffusion coefficient (De,B)
𝐷𝑒,𝐵 =

𝐷𝐸𝐶𝐹 𝜙𝑒
𝜆2

(8)

which describes the relationship between effective diffusion, free diffusion, void fraction
(ϕe ) and tortuosity.18

Equation 8 also describes the effective diffusivity in the membrane. However,

because knowing the effective diffusivity is imperative for most membrane experiments,
this constant has been found experimentally for a number of membranes and molecules,
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including the diffusion of glucose through pores in polycarbonate. This experimental
value will be used in preference to a calculated value. 32
All parameters use in this simulation are summarized in Table 1. Note that the
“outer boundary” concentration is being modeled at the outer wall of a capillary. This
concentration is the model’s “true” ECF glucose concentration, the concentration that
ZNF is used to determine.

Table 1. Physical parameters for brain-probe system.
Variable
V
c0P
c0B
hm
cc
wm
wb
rhoP
etaP
DP
DB
DM

Expression
Volumetric flow rate of perfusate
Initial glucose concentration in
perfusate/membrane
Initial glucose concentration in brain
Height of Membrane
Outer capillary (brain) glucose
concentration
Membrane thickness
Width of brain section
Density of Perfusate
Dynamic Viscosity of Perfusate
Diffusion Coefficient of glucose
in Perfusate
Diffusion Coefficient of glucose
in Brain
Diffusion Coefficient of glucose
in Membrane

Value
1.67x10-11

Units
m3/s

0.50

mol/m3

1.25
3.00x10-3

mol/m3
m

1.25

mol/m3

4.00x10-5
5.00x10-5
9.90x102
7.28x10-4

m
m
kg/m3
Pa s

8.30x10-10

m2/s

1.16x10-10

m2/s

7.62x10-11

m2/s

Ref
5
5

5
5
5

12
15
33
33
33

2,35

32

Values for volumetric flow rate, initial perfusate/membrane and brain
concentrations, membrane length, and outer boundary concentrations are the
specifications and results of McNay’s research.5 This is the experiment used to provide a
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dataset to confirm the accuracy of the simulation. The width of the membrane and brain
are justified in the Background. Density, viscosity and perfusate diffusivity are
calculated using the PRSV (the Stryjek-Vera modification of the Peng-Robinson equation
of state) model at 38.2°C. 33,34 The value for brain diffusivity is calculated using Equation
8 with 0.35 as the volume fraction of ECF in brain and 1.6 as the tortuosity factor. 35,2

4.3

Construction of Model

COMSOL 4.2, a FEM program, will be the main program used to model the
brain-probe system. COMSOL stores linear equations in the form Ax=b and then uses a
method called generalized minimal residual (GMRES) to solve the equations. GMRES is
an iterative method which follows the general method outlined above. 36

4.4

Mesh

One of the most important decisions in using FEM software is selecting the mesh
size. The mesh is what defines where calculations are conducted and how many degrees
of freedom there will be. If a coarse mesh is selected, the solution will likely not be
accurate because calculations are only taken at a few points. However, if the mesh is too
fine, it will take too long for the program to compute results, and no solution will be
reached. Another decision that has to be made is mesh shape. In a three-dimensional
model, the mesh can take any form; however, the most common shapes are either
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quadrilaterals or tetrahedra. Quadrilaterals are better suited for boxy geometries while
tetrahedra are better suited for round geometries, such as spheres and cylinders.
Similarly, the most common mesh shapes in two-dimensional modeling are quadrilaterals
and triangles.
Therefore, once a mesh shape has been selected, a balance must be struck. The
mesh must be fine enough that the solution is accurate, yet coarse enough that the
computer can provide a solution in a timely manner.

4.5

Data Processing

Because most laboratories using microdialysis only record outlet glucose
concentration, this is the only piece of data needed to be tracked during simulation to
verify ZNF. This is accomplished by integrating the concentration of glucose over the
surface of the outlet channel, generated directly by COMSOL.
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5

Results

5.1

Model Image/Drawing

5.1.1

Three-Dimensional (Asymmetric) Model

A three-dimensional model of the brain-probe system, as described in the
Background, was constructed using COMSOL 4.2. Three dimensions were used as a
starting point because in addition to radial and axial transport, there is angular diffusion
caused by the two bore holes connecting the inner cannula to the outer annulus. None of
these three directional flows seemed negligible.
Figure 8 shows the overall (A) and cutaway (B) geometry of the system being
modeled. The cutaway model shows the inlet perfusate channel (a), the outlet perfusate
channel (c), the membrane (d), and the brain layer (e). The gap that separates the inlet
and outlet channels (b), as well as the gap between the base of the flow regime and the
bottom brain layer (g), are stainless steel and have no interaction with the system, so they
are not modeled (i.e. an empty space). In the cutaway model, the two tubes that connect
the inlet and outlet perfusate channels can be seen, as well as the layer of brain beneath
the probe (h).
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Figure 8. Geometry of asymmetric brain-probe system. (A) overall (B)
cutaway. The probe has an overall diameter of 500 µm and height of 3
mm. The probe is then broken down into the following dimensions: (a)
50 µm, (b) 75 µm (c) 85 µm (d) 40 µm (e) 50 µm (f) 3 mm (g) 25 µm (h)
50 µm. The bore holes near the base of the probe have a diameter of
60 µm.

After working with the asymmetric model for some time, discrepancies were
found that questioned the overall validity of the model. The largest problem is the fact
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that the cross-sectional area COMSOL was calculating for inlet and outlet boundaries is
incorrect. The areas calculated differ significantly from a simple hand calculation (πr2 for
the inlet and π(ro2-ri2) for the outlet) based on the same radii.
Further unsettling is the fact that the accuracy of this error does not improve with
a finer mesh. Apparently, dimensions are not calculated using the mesh; meaning the
accuracy of dimensions is therefore not dependent on how well the mesh fits the
geometry. The dimensions are therefore calculated incorrectly by COMSOL at some
fundamental computing level. In fact, even when a simple two-dimensional ring is
examined in a separate model, the calculated area is different from both the asymmetric
model and a hand calculation. This problem led me to question the accuracy of all other
geometry based results, which includes outlet glucose concentration.
In addition to inaccurate geometric dimensions, the asymmetric model is
inconvenient to work with. With almost 520,000 elements in the mesh, it takes nearly 10
minutes to solve it at steady-state and over 7 hours to solve it with the transient model.
Due to the lack of confidence in the asymmetric model and the inconvenience of running
it, a more robust means for describing and modeling the brain-probe system was sought
after.

5.1.2

Axisymmetric Model

Initially, the three-dimensional asymmetric model was chosen over a radially
symmetric one because it was believed that the two bore holes at the base of the probe
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would cause an irregularity in the flow pattern of the active region, leading to a nonnegligible amount of angular diffusion. However, the use of an axisymmetric model
(Figure 9) was investigated after the geometric errors were found in the asymmetric
model. By assuming that there is no significant angular diffusion, the two bore holes, and
therefore the entire inlet channel, can be eliminated. To simplify things further, the inlet
for the perfusate was chosen to be the bottom boundary of the active region. With these
changes, the brain-probe system is still primarily the same; there is the outlet perfusate
channel (a), membrane (b) and brain layer (c). There is also still a stainless steel gap (e)
between the active region of the probe (d) and the bottom layer of the brain (f). All
symmetric models, unless otherwise stated, have identical dimensions to the overall
model and will therefore not be included in every figure.

NOTE: All further figures of probes have been rotated 90°
counterclockwise; the top of the probe is to the left.

Figure 9. Geometry of the two-dimensional, axisymmetric brain-probe
system. The probe has an overall radius of 250 µm and height of 3 mm.
The probe is then broken down into the following dimensions: (a) 85 µm,
(b) 40 µm (c) 50 µm (d) 3 mm (e) 25 µm (f) 50 µm. The perfusate enters
the model at the base of the outlet flow region.
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Testing of the validity of the new symmetric model was based on mass
conservation and fluid flow. A mass balance was conducted on each individual domain
and on the system as a whole. Overall, the system gains only 4.2 pmol/min of mass,
which is less than half of the mass gain in the asymmetric model. The full mass balance
can be found in Appendix B. The velocity profile in the perfusate region of the
symmetric model was also examined to make sure that the skewed parabolic shape
typical to annuli was conserved.
These factors show that, at the same parameters, angular diffusion at the base of
the probe is negligible and that a simplified, symmetric model can produce accurate
results. In addition to a higher level of confidence, the symmetric model is easy to work
with. With only 8,000 elements in the mesh, the model can be solved at steady-state in
less than 10 seconds.
Detailed instructions for constructing the two-dimensional steady-state brainprobe system in COMSOL can be found in Appendix C. While Appendix C is written
for people with no COMSOL experience, Appendix D holds a less thorough set of
instructions for people familiar with COMSOL. Appendix E has instructions for creating
a probe geometry that is completely adaptable to any size probe with similar design to the
CMA 12.
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5.1.3

Presentation of Results

COMSOL is able to output results in a variety of different ways. The two that
will be used in this project are two-dimensional renderings and line averages. Figures 10
and 11 are two-dimensional cutaways of results for the velocity and concentration profile,
respectively, using the parameters in Table 1. Note that after solving the twodimensional model, COMSOL wraps the results around the central axis to produce a
three-dimensional geometry with no angular diffusion.

Figure 10. Typical velocity profile of perfusate throughout probe using
parameters in Table 1. Units are in m/s.

Figure 11. Typical concentration gradient throughout brain-probe system
using parameters from Table 1. Units are in mM.
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Another useful post-processing computation COMSOL can be used to conduct is
a line average. By integrating over the outlet perfusate boundary and dividing by the
length of the boundary, COMSOL can be used to calculate the concentration of glucose
leaving the probe in mM.

5.2

Mesh

An extremely useful feature in COMSOL is the physics-controlled mesh
sequence. The parameters chosen by this function are based on hundreds of models
previously constructed in COMSOL that have similar geometries and physics packages.
For this simple model, the physics-controlled mesh is able to create a mesh that supplies
accurate results.
Within the physics-controlled system, a pre-defined mesh size that ranges from
extremely fine to extremely coarse can be chosen. To determine which size mesh
minimizes solve time while still providing an accurate solution, an iterative process was
used. The model was first solved with the smallest possible mesh; the outlet glucose
concentration provided by this solution was deemed the “true value”. The model was
then solved with an increasingly larger mesh size until the results produced were no
longer within a 95% confidence range of the true value.
For this model, COMSOL chose to construct the mesh using triangular elements.
Interestingly, all of the mesh sizes were within 99.9% of the “true value”. All of the
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concentration results in mM were identical out to the third decimal place. For this
reason, the mesh size was based on solve time, which ranged from 101s (extremely fine)
to 3s (extremely coarse). The mesh size of “Finer” (10s) was chosen because it had one
of the highest ratios for number of elements to solve time.

5.3

Sensitivity Analysis

A sensitivity analysis was conducted on each of the COMSOL model constants to
determine the parameters to which results are most sensitive. Each input variable was
independently tested at 13 different values over a range of 10% to 1000% of the normal
value. As the only experimentally measured system output, the probe outlet
concentration of glucose was used as the dependent variable. This concentration was
recorded for each test and graphed against parameter values to determine the sensitivity
of this key result to each parameter. As an example, the sensitivity data for perfusate
volumetric flow rate can be found in Table 2.
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Table 2. Raw data for glucose concentration sensitivity analysis of
perfusate volumetric flow rate (holding all other parameters constant).
Volumetric Flow Rate
(m3/s) x1011

% of Value
from Normal

0.17
0.84
1.12
1.52
1.59
1.65
1.67
1.69
1.75
1.84
2.51
3.34
16.70

10
50
67
91
95
99
100
101
105
110
150
200
1000

Outlet Glucose
Concentration
(mM)
1.196
0.819
0.755
0.698
0.691
0.684
0.683
0.681
0.675
0.668
0.628
0.598
0.522

% of Outlet
Concentration
from nominal
175.3
120.1
110.6
102.2
101.2
100.2
100.0
99.8
98.9
97.9
92.0
87.6
76.4

Appendix F shows results for each of the analyses, while Figure 12 summarizes
the key results. In order to validate ZNF assumptions, the COMSOL model must mimic
the experimental system as closely as possible. As can be seen in Figure 12, outlet
glucose concentration is most sensitive to volumetric flow rate. If volumetric flow rate is
off by an order of magnitude, the concentration results can be off by as much as 75%, or
0.51 mM. Later this fact will be proven as an advantage. Figure 12 also shows that
within an order of magnitude, perfusate density and viscosity have no significant effect
on outlet glucose concentration.
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Figure 12. Sensitivity analysis. The orange boxes represent 1000% of the
system parameter while the blue boxes represent 10% of the system
parameter. Outlet glucose concentrations are unaffected by order of
magnitude shifts in perfusate density or viscosity. The system parameters
are: volumetric flow rate (V), brain width (wB), diffusion coefficient of
glucose in the brain (DB), the membrane (DM) and the perfusate (DP),
perfusate density (rhoP), and perfusate viscosity (etaP).

5.4

Temperature

One potential complication is the formation of a temperature gradient within the
active region of the microdialysis probe. If a temperature gradient is present, the
perfusate and membrane properties would vary throughout the probe. If this is the case, a
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thermal package would have to be added to the model and the thermal characteristics for
each parameter would have to been found.
In order to determine if a thermal solver is necessary, a new three-dimensional
model, which represented the lower 14 mm of the probe, was created in COMSOL. A
three-dimensional model was chosen over a two-dimensional axisymmetric model.
Because there is only fluid flow and no diffusion or transport of mass across boundaries,
the problems associated with the above three-dimensional model were not seen. Figure
13 shows the lower 6 mm of this model; the rest of the model is identical to the top (left)
most section. It is assumed that the probe is implanted 5 mm into the head of the rat.
Therefore, in addition to the 3 mm of active membrane that is in the rat head, there is a
2 mm section of non-active probe also in the head. The remaining 9 mm of the modeled
probe is outside of the head and exposed to ambient conditions.

Figure 13. COMSOL model used to evaluate presence of a temperature
gradient. Units are in µm.
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The model is broken up into three sections to represent these three distinct
temperature regions: the active region of the probe in the head, the non-active section in
the rat head, and the non-active region that is not in the head. The geometry of the
bottom section is identical to the three-dimensional version of the glucose model, except
without the brain section. The upper two sections are a simple extension of the
concentric design, the membrane being replaced with a stainless steel casing. In each
section, the relevant boundary condition is the temperature of the environment. The outer
surface of the membrane or stainless steel casing is therefore set to a constant temperature
appropriate for that section. Because the brain is the source of heat, the domain itself did
not have to be modeled and was simulated by putting the thermal boundary condition on
the outer wall of the membrane. The lower two sections, which are in the head, have a
boundary condition of 38.2°C, the average temperature of a rat brain. 37 The upper 9 mm
of the probe has a boundary condition of 23°C, room temperature.
The COMSOL model was run at steady-state using creeping flow and thermal
physics packages. The transport of glucose was not modeled because it is irrelevant to
the thermal profile. All other parameters are identical to the ones used in the
concentration model (Table 1). Results for the entire probe are shown in Figure 14.
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Active Region

Figure 14. Temperature profile throughout lower 14 mm of microdialysis
probe. Units are in K. The first (right) 3 mm are the active region of the
membrane.

To get to the active region, the perfusate has to travel through the connecting
tubes at the base of the probe. Figure 14 shows that by the time the perfusate reaches
these connecting channels, the perfusate has reached complete thermal equilibrium with
the brain and there is no temperature gradient in the active region of the perfusate flow.
To emphasize this fact, Figure 15 shows the temperature profile along the inner
wall of the outer cannula from the base of the probe, including the section below the
connecting tubes. As can be seen, when the perfusate leaves the active region, the
temperature at the inner wall (the surface furthest from the boundary condition) is
38.0°C, which is within 99% of steady-state. With such a minute variation in
temperature along the active region of the probe, it is a valid assumption to say that
temperature is constant.
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Figure 15. Temperature profile for the annulus of the probe. The first (left) 3 mm are the
active region of the membrane. The head, and therefore heat source, ends at 5 mm. The
remaining 9 mm is open to ambient conditions.

5.5

Zero Net Flux

5.5.1

Validity of Model

To confirm that this model accurately describes in vivo experiments, it was run at
steady-state using the set of parameters in Table 1 that describes the experimental system
run at SUNY Albany.5 As can be seen in Figure 16, the model accurately recreates the
experimentally-determined point of ZNF, and the model’s predicted data describes the
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slope of the data well with an r2 of 0.90. The line of best fit for the data only has an r2 of
0.91.

Net Change in Concentration (mM)
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Figure 16. Comparison of experimental data (♦) with model results
(orange). No fitting parameter is used.5

Importantly, all model parameters were based either on experimentally set
parameters (flow rate, inlet concentration) or literature (diffusion coefficients, viscosity,
density), using no “fitting” parameters to adjust the model. It can therefore be concluded
that the evidence supports this model as an accurate representation of the brain-probe
microdialysis system. Because this model was run at steady-state, the fact that the model
fits the experimental data shows that assumptions made in using ZNF to analyze
microdialysis data from this experiment are valid.
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5.5.2

Implications of ZNF

In practice, in vivo experiments generate ZNF for an experimental condition and
then use the slope to relate outlet concentrations. This is possible due to the fact that the
slope of the ZNF line is dependent only on the volumetric flow rate and the three
diffusivities. The slope is not dependent on the brain concentration or on which inlet
glucose concentration is chosen. Figure 17 is the result of changing the brain glucose
concentration from 1.25 mM to 1 mM while keeping all other parameters the same. This
shows that the diffusivities of a given brain-probe system can be characterized with one
number, the slope of the ZNF plot. The perfusate diffusivity will remain constant as long
as the same aECF is used. The membrane diffusivity will not change as long as the same
membrane material is used. Brain diffusivities are relatively constant throughout a
species, but may change with age and disease.4
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Figure 17. ZNF plot (using model data) for the same specimen at a brain
concentration of 1.25 mM (orange) and after a concentration drop of 0.25
mM to 1.00 mM (blue).

Applying the concept in Figure 17 to the fact that the ZNF slope from one brain
can be applied throughout a set of similar rats can be extremely useful. By realizing that
when the brain concentration changes, the ZNF plot simply “shifts” to accommodate a
new x-intercept, an equation can be crafted
cB = cin -

cout - cin
slope

(9)

to quickly calculate brain concentration. To solve this equation only one set of
input/output concentrations is needed, once the ZNF slope is known for the specific
species. This means effectively, statistics aside, that brain glucose concentrations can be
known with only one measurement.
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5.5.3

Time to Steady-State

The goal of the second hypothesis was to determine the shortest brain activity, i.e.
a thought, that microdialysis can measure and the limiting factor of the temporal
resolution. The three factors that could be limiting are sample size, time to steady-state
within the probe, and dispersion in the exit tubing.
The simplest factor to describe is sample size. One common means for measuring
outlet glucose concentrations is taking an aliquot of the dialysate and running an off-line
fluorometric analysis. Depending on the sensitivity of the analytical instrument, the
concentration of the analyte in the dialysate and the flow rate of the perfusate, it usually
takes 5 to 10 minutes to collect one sample. The best possible temporal resolution is
therefore the size (divided by the flow rate) of the sample. For any further calculations, it
will be assumed that outlet perfusate is collected for 5 minutes to form a large enough
aliquot needed for analysis.4
To determine the effect of the probe on temporal resolution, a transient COMSOL
model was created to determine how long the brain-probe system takes to reach steadystate, both at startup and in response to a thought. The model is identical to the one in
Figure 9 except it was run as a transient model instead of at steady-state. The system
simulated is initially at rest (no flow) and at 250 s, the rat has a 250 s thought. The model
was run out to 750 s and the thought consumed 0.25 mM, making the brain glucose
concentration 1.00 mM. Appendix G details instructions for constructing a transient
model.

Outlet Glucose Concentration (mM)
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Figure 18. Transient response of brain-probe system to a 0.25 mM drop in
brain concentration (black) with an inlet glucose concentration of: 1.0 mM
(orange), 0.75 mM (blue), 0.5 mM (red), and 0.25 mM (green).
NOTE: The 15 s delay between the input step and the outlet slope is due to
the time it takes the fluid to travel through the probe.

An interesting note is that the decrease in outlet glucose concentration when
steady-state is re-achieved is independent of perfusate concentration. In the case of
Figure 18, the drop in brain glucose concentration was 0.061 mM for all perfusate
concentrations. This phenomenon can be attributed to the idea of a constant slope
presented with Figure 17.
Table 3 shows that the closer inlet concentration is to the brain concentration, the
quicker the system reaches steady-state. Therefore, the use of a perfusate with a
concentration close to that of the brain will improve temporal resolution. But even
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perfusate with a concentration significantly different from that of the brain still results in
temporal resolution on the order of 1-2 minutes at the outlet of the probe.

Table 3. Time it takes system to reach steady-state after a 0.25 mM drop
in brain concentration at several levels of precision.
Proximity to
Steady-State (%)
110
101
100.1
100.01
100.001

Time to steady-state (s)
Cin = 0.25 mM
Cin = 1.00 mM
18
0
47
32
71
40
95
65
119
89

Currently, researchers are waiting 20 minutes after startup to begin taking
samples. Table 4 shows that the time to steady-state for startup is similar to the reaction
time to a thought. However, waiting longer than 2 minutes to start sampling is still
advisable in case there are any unforeseen changes caused at startup.

Table 4. Time it takes system to reach steady-state from start up at several
levels of precision (cin=0. 25 mM).
Proximity to
Steady-State (%)
90
99
99.9
99.99
99.999

Time to steady-state
(s)
21
43
67
90
113
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Consequently, it can be seen that the brain-probe system will regain steady-state
within 1-2 minutes after any reasonable perturbation. The time for which the output is at
the actual thought concentration has shrunk by one minute. So far, if the analytical
device requires 5 minutes of gathering for an aliquot and system parameters are similar to
those used in the transient model, no brain process lasting less than 6 minutes will be
measurable. The effect of Taylor dispersion on temporal resolution will be discussed
later.

5.6

Reverse Microdialysis

Another reason to accurately model microdialysis is to help develop its use as not
only an analytic device, but also as a drug delivery unit. An interesting feature of the
microdialysis probe is that because transport across the membrane is controlled by a
concentration gradient, a perfusate can be designed so that the probe runs in “reverse”.
That is, if the concentration of an analyte is higher in the perfusate than in the brain, the
analyte will be transported through the membrane and into the brain. This method of
drug delivery could have far-ranging implications, especially for delivering drugs that are
too large to pass through the blood-brain barrier (the dense lining around capillaries). 38
Reverse microdialysis can be seen in Figure 16; the experimental points to the
right of the x-intercept have an inlet concentration greater than the brain concentration;
therefore, they have a negative net change in glucose concentration, meaning glucose was
lost to the brain.
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When modeling ZNF, perfusate concentrations were relatively similar to those in
the brain; the maximum deviation was 0.75 mM. Drug delivery deals with adding a
component at a significant concentration that is otherwise absent from the brain.20,39 The
drug can be delivered either highly concentrated over a short period of time as a pulse or
at a lower, constant concentration. It has been shown that the ZNF model works well at
concentrations near the brain. However, it is a possibility at extreme concentrations, the
assumptions made in the boundary conditions and homogenization of the brain could
break down and provide useless data. For this reason, a separate model was created
(Figure 19) which is identical to the first model except that the brain section is enlarged.

Figure 19. Model geometry for reverse microdialysis. The probe itself
still has an overall radius of 250 µm and height of 3 mm. The probe is
then broken down into the following dimensions: (a) 85 µm, (b) 40 µm (c)
50 µm (d) 150 µm (e) 3 mm (f) 25 µm (g) 150 µm. The perfusate enters
the model at the base of the outlet flow region.

In the ZNF model, it was assumed that the brain tissue on opposite side of
capillaries from the probe would not be affected by the transport of glucose to the probe
because the capillaries are the source of the glucose. Drugs that are delivered using
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microdialysis will most likely be too large to pass through the blood-brain barrier (BBB)
and will therefore not be affected by the capillary. For this reason, the brain section
needed to be extended to determine the transport of the drug throughout the entire brain.
It turns out that beyond 200 µm from the probe, changes in concentration are negligible.
Anything past 200 µm can effectively be viewed as “infinity” from the probe. In doing
this, it is assumed that the capillary does not play a significant role in this process,
specifically that the response time of the capillary to changes in brain drug concentration
is much slower than action of the probe.
To ensure the model is as robust as possible, it was tested at extreme conditions.
The system modeled is that of glucose delivered in a pulse to the brain. This could be
used for patients severely lacking glucose and in need of fast relief. The initial
concentration for glucose in the immediate region of the brain (50 µm) was set to 0.5
mM, while the outer reaches of the brain (150-200 µm) are set to the normal 1.25 mM.
At t=1s, the inlet perfusate concentration was changed to 100 mM for a duration of 5s, at
which point the concentration was held constant at 1.25 mM. All other parameters are
unchanged from the ZNF simulation (Table 1).
Figure 20 shows the concentration of glucose 50 µm from the probe over time.
As can be seen by the insert, the depleted region is at first serviced by the non-depleted
brain immediately adjacent to the depleted region. However, after a short period, the
overwhelming amount of glucose from the probe takes over and the concentration sharply
increases.
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Figure 20. Brain glucose concentration 50 μm from the probe when probe
is perfused with a 100 mM glucose spike for 5 seconds. Brain starts at
0.5 mM and perfusate is reduced to 1.25mM at 6 seconds. The inset is a
close-up of the first 15 seconds of the simulation.

These results show that COMSOL and FEM can be used successfully to model
reverse microdialysis.
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6

Impact of Tubing on Temporal Resolution

It is important to determine how long a signal has to last in order to get a reading
unaffected by Taylor dispersion. As stated in the Background, it was believed that the
length of the exit tubing causes significant signal dilution and therefore limits the
temporal resolution of results. The derivation that follows is an adaptation of G.I.
Taylor’s original work. 40 Before the dispersion process is derived, the basic principles of
Taylor dispersion will be discussed.

6.1

Taylor Dispersion

Dispersion is the axial mixing of a fluid due to the coupling of diffusion and a
radial velocity gradient. In a pipe, fluids in the center travel faster than near the walls,
where velocity is zero due to no slip. One way to visualize this is by looking at the
transport of a pulse, as in Figure 21. Due to no slip at the wall and no stress at the center,
a parabolic flow profile is formed. If a cross-section of the tube is examined at the front
of the parabolic profile, the concentration at the center is higher than at the walls. This
radial concentration gradient will cause the solute to diffuse from the center radially
outward towards the less concentrated, slower moving fluid. Additionally, fluid at the
rear of the pulse is more concentrated at the walls, because the solute is moving slower.
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This will cause solute in the rear to diffuse inward to the faster flowing fluid. The final
result of this phenomenon is that the signal will spread out as it travels along the tube.
Taylor dispersion is therefore the axial spreading of solute caused by a radial velocity
gradient.

Figure 21. Example model of Taylor Dispersion, for a pulse. 41

The system being examined (Figure 22) is a simple one. It is essentially fully
laminar flow in a horizontal pipe. As described in the Background, Stoke’s flow is a
simplified form of Navier-Stokes, which accurately describes laminar flow. Therefore,
even though the flow in the tube is technically considered creep flow, deriving Taylor
dispersion as laminar flow will still provide accurate results.
r
Detector

z
2m

Figure 22. Diagram of system to be examined. Diagram is not to scale.
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6.2

Velocity Profile

When the equations of continuity and motion are adapted to this system
dp R2

r2

vz = − dz 4μ �1 − R2 �

(10)

is derived which represent the parabolic flow profile. In developing Equation 10, it was
assumed that: density, temperature, and material properties are constant, the system is at
steady-state, the velocity vector is only dependent on the radial (r) coordinate but only
non-zero in the axial (z) direction, no body forces exist, no slip at the walls, and no end
effects. No end effect is a valid assumption because the length of the tube is so long
compared to the length of the end effect zone.
Boundary conditions used to develop the flow profile are
BC1: vz (r = R) = 0;

BC2:

dvz
dr

�

r=0

= 0.

(11)

In future derivation steps, it will be helpful to note that
dp R2

and that

Therefore

vz,max = vz |r=0 = − dz 4μ
〈vz 〉 =

2

R2

R

∴vz = vz,max �1 dp R2

∫0 vz (r) rdr = - dz 8μ �1 vz =2〈vz 〉 �1 -

r2

R2

r2
R2

� =

r2

R2

1
v
2 z,max

�

.

�

(12)

(13)

(14)

where vz is mass average velocity and 〈vz 〉 is the average velocity at a cross section of
tubing. vz,max is found at the center of the tubing where there is no stress.
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6.3

Concentration Profile

Once the velocity profile was described, the species equation of continuity was
adapted to the system and resulted in
∂cA
∂t

+ vz

∂cA
∂z

1 ∂

= DA � r ∂r �r

∂cA
∂r

� +

∂2 cA
∂z2

�

(15)

where cA is the concentration of glucose in the fluid and DA is the coefficient of diffusion
for glucose in aECF.
In addition to the using the same geometric assumptions stated in the Velocity
Profile section, it was additionally assumed that there is no reaction, that concentration is
independent of angle (dependent solely on the r and z coordinates), and that the diffusion
coefficient is constant.
The boundary conditions for Equation 15 are
BC3: cA (t, r = 0, z) is bounded;

2π

1

BC4: ∫0 ∫0 cA′ r ∂r ∂φ.

(16)

where φ is the angular coordinate and ca’ is a variable that will be explained below.
For this case, in which an approximation for long times are desired, it is sensible
to use a coordinate system that translates with the average velocity. This new traveling
variable, δ, is
δ ≡ z -〈vz 〉t

in which the derivative of is
D

Dt

≡

∂

∂t

(17)

∂

+ 〈vz 〉 ∂z.

Applied to the concentration and solved for ∂/∂t

(18)
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∂cA

=

∂t

DcA
Dt

− 〈vz 〉

∂cA

1 ∂

∂cA

(19)

∂z

Using Equation 19 and applying it to Equation 15 along with the axially shifted
coordinate in Equation 17 produces
DcA

∂cA

(20)

vz′ ≡ (vz − 〈vz 〉) = 〈vz 〉 �1 − 2 R2 �.

(21)

∂δ

= DA � r ∂r �r

�+
∂r

∂2 cA

�

Dt

where

+ vz′

∂δ2

r2

is the deviation velocity.

Equation 20 is then nondimensionalized using
θ=

cA
�cA,ref ;

ξ = z�L ;

η = r�R ;

γ=

〈vz 〉t�
L

(22)

where θ, η, ξ, and γ are the dimensionless concentration, radial, axial, and time variables,
respectively. cA,ref is an arbitrary reference concentration. The specific value of cA,ref is
not needed because it will not be present in the solution. All variables are designed so
that the entire domain is scaled to range between 0 and 1.
The result of nondemensionalizing and rearranging Equation 20 is
R Dθ

where

v ≡
and

∂θ

Pe L �Dγ + v ∂δ� =

1 ∂

∂θ

R 2 ∂2 θ

�η ∂η� + �L �
η ∂η

∂δ2

r2
v′z
�〈v 〉 = �1 − 2 R2 � = (1 − 2η2 )
z

Pe =

〈vz 〉R
DA

.

(23)

(24)

(25)
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The Péclet number, Pe, is a dimensionless variable that relates axial convection to radial
diffusion. Taylor assumed that in systems where dispersion is prevalent, Pe » 1;
convection is much faster than diffusion. The Pe number for this system is 60, which is
large enough for Taylor dispersion. 42
A decomposition of the concentration is then proposed so that
θ (η, ξ, γ) = 〈θ〉 (ξ, γ) + θ′(η, ξ, γ)

(26)

where 〈𝜃〉 is the cross-sectional average of θ which is independent of r. θ’ is the

difference between the average concentration and the actual concentration at any point.
Generally, the decomposition is made with the expectation that 〈θ〉 » θ’.
Applying this decomposition to Equation 23 results in
R D〈θ〉

Pe L � Dγ +

Dθ′
Dγ

∂〈θ〉

+ v � ∂δ +

∂θ′

�� =
∂δ

1 ∂

R 2 ∂2 〈θ〉

∂θ

�η ∂η� + �L � �
η ∂η

where use was made of the fact that 〈𝜃〉 is independent of η.

2

∂δ

+

∂2 θ′
∂δ2

�

(27)

The next step is to take the cross-sectional average of Equation 24 in order to

obtain an equation for 〈𝜃〉. First however, it is useful to note that two properties of the
decomposition in Equation 26 are

〈〈θ〉〉 = 〈θ〉

and

〈θ′〉 = 0.

(28)

The cross-sectional average of Equation 27 is
R D〈θ〉

∂θ′

R 2 ∂2 〈θ〉

Pe L � Dγ + 〈v ∂δ 〉� = �L � �

∂δ2

�.

(29)

Because this derivation is interested in dispersion at long times, or long tubing, L » R.
This means that the final term in Equation 29 can be considered negligible compared to
the other terms, resulting in
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D〈θ〉
Dγ

∂θ′

= - 〈v ∂δ 〉

(30)

which shows that Taylor dispersion is due to the averaged product of deviations from the
mean velocity and concentration. To solve Equation 30 for 〈𝜃〉, θ’ needs to be defined.

To generate an equation for θ’, subtract Equation 29 from Equation 27 to produce
R Dθ′

∂〈θ〉

Pe L � Dγ + v � ∂δ +

∂θ′

R

∂θ′

1 ∂

∂θ′

R 2 ∂2 θ′

�� = Pe L 〈v ∂δ 〉 + η ∂η �η ∂η � + �L �
∂δ

∂δ2

.

(31)

This equation cannot be solved analytically and must be approximated by
neglecting terms based on relative magnitudes. Again, because L » R, the third term on
the right-hand side of Equation 31can be neglected. It can further be assumed that
L » PeR, therefore allowing the first term on the right-hand side to be neglected. This
leaves the radial diffusion term as the predominant term on the right-hand side of
Equation 31.
Even though it is assumed that L » PeR, at least one term on the left-hand side of
Equation 31 needs to be significant in order to balance out the remaining term on the
right-hand side. Taylor assumed that 〈𝜃〉 » θ’, which leaves the average axial convection

term as the dominant term on the left-hand side Equation 31. These approximations
reduce Equation 31 to
R

Pe L v

∂〈θ〉
∂δ

=

1 ∂
η ∂η

∂θ′

�η ∂η �.

(32)

Equation 32 can be solved for θ’ by integrating twice with respect to η and
applying the boundary conditions in Equation 16. The result is
θ′ =

PeR ∂〈θ〉 η2
L

∂δ

which when used in Equation 30 produces

�4 +

η4
8

1

+ 12�,

(33)
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D〈θ〉
Dγ

=

〈vz 〉R2 ∂2 〈θ〉

48DA L ∂δ2

.

(34)

𝜕〈𝑐𝐴 〉

𝜕2 〈𝑐𝐴 〉

When this equation is dimensionalized and the axially shifted coordinate system is
removed
𝜕〈𝑐𝐴 〉
𝜕𝑡

where

+ 〈𝑣𝑧 〉

K =

𝜕𝑧

=𝐾

R2 〈vz 〉2
48DA

(35)

𝜕𝑧 2

.

(36)

K is defined as the Taylor dispersion coefficient and has the same units as a
diffusion coefficient. This fact shows that dispersion, while truly a combination of the
parabolic velocity profile and radial diffusion, has the appearance of axial diffusion.
The next step is to get an explicit equation for 〈𝑐𝐴 〉. Equation 35 is a second order

PDE with 〈𝑐𝐴 〉 as the only dependent variable. The equation can easily be solved using a
Fourier transform. The result of this transform is
∂CA
∂t

+ 〈𝑣𝑧 〉i2πh𝐶A = K(i2πh)2 𝐶𝐴

(37)

a first order ODE where h is the independent variable in Fourier space and CA is the
Fourier concentration. Solving for CA
CA =G(h) e(K(i2πh)

2

-〈vz 〉i2πh)t

(38)

where G(h) is the signal function, or the form of the original input function. By taking
the inverse Fourier, g(z) is convolved with the inverse of the exponential term

〈cA 〉(z) = g(z) *

1

�4K𝑡out π

z2
�
-�
4K𝑡out

e

2
�z - y�
�
4K𝑡out

-�

=

∞
1
∫ g(y)e
�4πK𝑡out -∞

dy.

(39)
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Where tout is the time it takes the fluid to reach the analytical instrument. Note that the
second term in the convolution has the form of a normal Gaussian distribution. The y in
Equation 39 is a dummy variable used to pass one function over the other and to
effectively smear them together.
Now there is an explicit equation that provides the average concentration profile
of the solute as a function of axial distance, which is related proportionally to time in
tubing by the average velocity. This can be used to determine at what point signals
become indistinguishable from each other.

6.4

Convolution

Equation 39 is in the form of a convolution. Essentially, a convolution takes one
function and rubs another function over it, causing smearing. As can be seen in Figure
23, there is a signal function (A, steps) and a smearing function (B, Gaussian curve). The
signal is smeared by the Gaussian curve. The graph in Figure 23.C is the result. The
output still has the same general form as the signal; however, the peaks have started to
blend together. If the width of the bell curve in Figure 23.C is increased, the two
individual peaks will eventually become indistinguishable from each other and no useful
data will be attainable.
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A
B

C

Figure 23. Example of Convolution. A) signal, B) smearing function, C)
result.

6.5

Signal

For this system, the signal is the concentration profile that enters the exit tubing.
Shown again in Figure 24 (originally in Figure 18), this profile was approximated by a set
of Boltzmann sigmoidal equations.

Glucose Concentration at Sampling point
(mM)
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Figure 24. Plot of actual signal (blue) compared to Boltzmann sigmoidal
(orange) fit (r2 = 0.9996). The data is originally found in Figure 18; a 250
s signal with one minute of dilution due time to steady-state in the probe.

The Boltzmann sigmoidal
cA = B +

T−B

h −t
� a �
m

(40)

1+e

where B is the concentration during the signal (minimum), T is the nominal concentration
(maximum), ha is the time at which the concentration is halfway between B and T, and m
is the slope of the curve at t = ha, only encompasses one concentration change. For that
reason, one sigmoidal models the drop in concentration (100 to 400s), while a second
function models the concentration increase (400 to 750s). The first 100s was not
modeled because the focus is on the impact dispersion has on signals, not startup.
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For both the decrease and increase, the equations used are identical except the
slope (m) is opposite and the half-time (ha) is different. When compared to the
COMSOL data, the Boltzmann sigmoidals fit with an r2 of 0.9996. To fit in with
Equation 39, the Boltzmann fit has to be shifted from the time domain (t) to the space
domain (z). This is done by multiplying m, h, and the time domain by the average
velocity in the tubing.

6.6

Effect of Taylor Dispersion on Concentration Results

Applying the adjusted Equation 40 to Equation 39 in the context of the relevant
system (shown in Figure 22 and described in Table 5) and running the convolution
function produces Figure 25. 1,000 seconds were added to the beginning and end of the
signal so that the convolution of the ends (which MATLAB treats as a concentration of 0)
does not affect the actual signal. The complete MATLAB mfile used for this model can
be found in Appendix H. A second mfile was created that shows the state of the signal as
it travels down the tubing. This transient version can be found in Appendix I.

Table 5. Physical parameters for exit tubing.
Variable
L
V
D
R
rhoP
etaP
K

Expression
Length of tubing
Volumetric flow rate
Diffusion coefficient of glucose in perfusate
Inner radius of tubing
Dialysate density
Dialysate kinematic viscosity
Dispersion coefficient

Value
2
1.67x10-11
8.3x10-10
1.075x10-4
990
7.28x10-4
6.22x10-8

Units
m
m3/s
m2/s
m
kg/m3
Pa s
m2/s
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Figure 25. Convolution results for system. Times shown are the times it
takes to get from 99% of the nominal concentration to 101% of the
concentration during the brain process.

Figure 25 shows that by the time glucose reaches the detector, the signal
(originally 250s wide) has dispersed 246 s, leaving only a 4 s duration that is at the true
brain process concentration. This degradation includes time to steady-state in the probe
and dispersion in the exit tubing; 185 s of the total degradation time is due to dispersion.
Keeping in mind that the analytical instrument requires sampling for a duration of 300 s
(five minutes), Figure 25 shows that it is impossible for an aliquot to accurately reflect
the concentration during the brain function. This idea is easier seen in Figure 26 where
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the output graph is separated into samples, and the concentrations both at the outlet of the
probe and at the end of the exit tubing are shown.

0.6826 mM

0.6826 mM

0.6826 mM

0.6420 mM

0.6826 mM

0.6826 mM

0.6824 mM

0.6432 mM

0.6724 mM

0.6713 mM

0.6826 mM

0.6826 mM

0.6826 mM

0.6826 mM

Figure 26. Concentrations read by analytical instrument. The graph is
broken up by the dashed lines into aliquots gathered for 5 minutes. The
numbers at the top (represented on the graph by blue squares) are the
concentrations the analytical instrument would read if placed at the outlet
of the probe. The numbers at the bottom (represented on the graph by red
squares) are the concentrations the instrument would read when placed at
the end of 2 m of exit tubing.

None of the aliquots in Figure 26 provide the true outlet glucose concentration.
To procure at least one valid sample of the brain function concentration, the brain process
needs to last at least as long as twice the sampling time, plus the time of dispersion due to
the probe and the exit tubing. For example, if the analytical instrument requires five
minutes of sampling, the probe reaches steady-state in 61 s, and the signal experiences
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185 s of dispersion, the original signal needs to last longer than 846s (5 min*60 s/min * 2
samples + 61 s to steady-state + 185s of dispersion). This concept is shown more
succinctly by
𝑡𝑠𝑖𝑔𝑛𝑎𝑙 > 2 ∗ 𝑡𝑠𝑎𝑚𝑝𝑙𝑒 + 𝑡𝑠𝑡𝑒𝑎𝑑𝑦−𝑠𝑡𝑎𝑡𝑒 + 𝑡𝑑𝑖𝑠𝑝𝑒𝑟𝑠𝑖𝑜𝑛 .

(41)

Equation 41 can divided through by tsignal to form a dimensionless group, the
Vinciguerra number
Vi =

where

2∗tsample +tsteady−state +tdispersion
tsignal

2 ∗ t sample =

𝑡𝑠𝑡𝑒𝑎𝑑𝑦−𝑠𝑡𝑎𝑡𝑒 =

and

0.85
√ vz

2mmin
,
V̇⌊c⌋MW

+ 7000Lp +

(42)

(43)

5x10−5
�Dlim

− 45,

KL

t dispersion = 6.5� v3 − 50.
z

(44)

(45)

is produced to determine if, given a set of experimental parameters, an accurate
measurement could be seen. If Vi is less than 1, then one of the aliquots taken, if
sampled continuously, will contain the true glucose concentration during the brain
function.
The first term in the numerator gives the time it takes to collect two aliquots based
on the minimum mass limit for the analytical device (mmin), the volumetric flow rate
through the tubing (V̇ ), the lowest possible analyte concentration (⌊c⌋), and the molecular

weight of the analyte (MW). This term represents the absolute smallest aliquot that could
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be read by the specified analytical instrument. If aliquots taken are larger than the
minimum, this term should be replaced by the collection time for two aliquot (volume of
aliquot / volumetric flow rate of perfusate).
The second term in the numerator is an approximation for the amount of signal
degradation due to time to steady-state in the probe. The coefficients for this term were
fit from an extensive set of data which can be found in Appendix J. This correlation is
based on the velocity of the perfusate in the outlet flow region (vz), the length of the
active region of the probe (Lp), and the limiting diffusion coefficient (Dlim). Note that the
coefficients in this term are dimensional and therefore, units for velocity, length and
diffusivity have to be in m/s, m and m2/s, respectively. The term will provide an
approximation for time to steady-state accurate to within an order of magnitude for
steady-state times greater than 30s
The final term in the numerator approximates the amount of signal degradation
due to Taylor dispersion in the exit tubing. Again, the coefficients for this term were fit
from a set of data found in Appendix J. This approximation is based on the dispersion
coefficient (K), the length of the exit tubing (L), and the average velocity through the
tubing (vz). This term is accurate to within 5% for any dispersion times greater than 40 s
and within 10% for times greater than 30 s.
No other dimensionless groups that relate signal length to analytical sensitivity
and dispersion are apparent in literature. Figure 27 shows a brain process lasting 846 s
and the associated dispersion given the same parameters used in Figure 26. The Vi
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number for this case is 1, meaning that at least one of the aliquots reflects the true outlet
glucose concentration, as seen in Figure 27.

0.6826 mM 0.6826 mM 0.6826 mM 0.6420 mM 0.6217 mM 0.6217 mM 0.6733 mM 0.6826 mM 0.6826 mM

0.6826 mM 0.6826 mM 0.6824 mM 0.6422 mM 0.6217 mM 0.6230 mM 0.6720 mM 0.6826 mM 0.6826 mM

Figure 27. Concentrations read by analytical instrument in the case where
the Vi number is 1. The graph is broken up by the dashed lines into
aliquots gathered for 5 minutes. The numbers at the top (represented on
the graph by blue squares) are the concentrations the analytical instrument
would read if placed at the outlet of the probe. The numbers at the bottom
(represented on the graph by red squares) are the concentrations the
instrument would read when placed at the end of 2 m of exit tubing.
While Taylor dispersion in the exit tubing does not have a significant effect on the
concentration read by the analytical instrument, it does increase the length of the smallest
measurable thought, by more than 4 minutes in the above case.
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7

Discussion

7.1

Validity of model

It was hypothesized that assumptions made in using zero-net-flux to analyze
microdialysis data are accurate. The major assumption tested was that the system is able
to reach steady-state. It was also hypothesized that the system takes less than 15 minutes
to reach steady-state. By creating a three-dimensional finite element model of the
system, it was possible to validate all assumptions.
In addition to the proof of validity given above (Figure 16 in particular), a mass
balance on the model is given in Appendix B. The model has an overall relative mass
imbalance of 0.60%, an acceptably small error. There are, however, some limitations to
the usefulness and robustness of the model. The largest inhibiting factor for this model is
the assumption made in simplifying the brain. The boundary condition is constant at the
nominal brain ECF concentration, regardless of brain activity and external influences. In
reality, the source of glucose is the capillaries and the concentration of glucose in the
blood stream varies in time and is even dependent on brain activity. However, because I
am interested solely on ECF glucose concentrations, I am able to eliminate the capillaries
from the model and replace them with a boundary condition that reflects nominal ECF
concentration levels.
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Another limiting aspect is the fact that the reaction term is built into the effective
diffusion coefficient. Coupled with the assumed boundary condition, the effective
diffusion coefficient is able to accurately describe the tortuous path glucose molecules
take from capillary to the probe and the consumption of glucose by brain cells. This
combination works well with glucose, but could fail for other molecules that do not
behave similarly. For instance, molecules that react in the ECF or molecules that do not
react at all will have to be modeled differently. For the most part, they should be able to
be worked into an effective diffusion coefficient, just as glucose is, but the process for
deriving that coefficient may be different.
The model also has a size limitation. Just as continuum mechanics cannot
properly describe molecular and atomic interactions, this model cannot describe noncontinuum interactions; this is due to the homogeneous assumption of the brain.
Fortunately in this aspect, the probe itself is the limiting agent and not the model. Probes
can only be manufactured so small, and are therefore limited in their spatial selectivity.
They cannot, for instance, measure the concentration of neurotransmitters being passed
between a certain neuron. As long as microdialysis probes remain in the analytical realm
of continuum mechanics, this model can provide an accurate description of the system.
Even with the three limitations found above, it has been shown that microdialysis
is an accurate and efficient means for measuring brain ECF concentrations, that ZNF is a
valid tool for translating microdialysis data into true concentrations, and that the finite
element model presented here can properly describe a brain-probe system.
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7.2

Comparison to Literature

As stated above, theoretical approaches to modeling microdialysis tended to be
specific and over complicated.21 For this reason, results will only compared to other
numerical approaches. Both Norton et al. and Wang et al. modeled an in vitro system
and found times to steady-state of 20 s and 30 s, respectively.26,27 It makes sense that
their time to steady-state is shorter because, as Zetterström discovered, glucose diffusion
in brain tissue is much slower than in aECF.23 If the brain domain is removed and the
outer boundary of the membrane is set to nominal brain concentration, the probe can
effectively be modeled as in a well-stirred beaker. Modeling the probe this way, the time
to steady-state of 45 s, which is close to results from Norton et al. and Wang et al.
While Norton et al. modeled exit tubing dispersion in MATLAB (they also used a
sigmoidal signal function), Wang et al. quantified the dispersion using experimental
procedure. Results presented here for dispersion times are very close to those of Norton
et al., which helps verify the validity of this approach. Wang et al. only presented data
from one trial, and it was in graphical form. However, when experimental parameters are
estimated and entered into the MATLAB file, dispersion times are similar.27

7.3

Implications

Once microdialysis, ZNF, and this model have been established, the next step is
finding a use for these results.
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7.3.1

Parameter Sensitivity

Prior to this model, the only sensitivity data that was available was on the
analytical instruments. A detailed description of the effect that experimental parameters
had on concentration results did not exist. By modeling the entire system and by being
able to individually set each of these parameters, it is now possible to determine the
sensitivity of results to any parameter. The sensitivity analysis is not limited to one
parameter; the model allows for changing more than one parameter at a time. This is
helpful in designing the experiment. For instance, from the results above, it is now
apparent that it is not necessary to find the exact perfusate density; any value within
reason would produce valid results.

7.3.3

Future Work

There are many areas of microdialysis still to be explored. This model will
hopefully aid in opening up these fields and improving the techniques. One way to
improve the robustness of the model would be to un-simplify the brain. If using
COMSOL, a homogeneous brain material would still be needed for continuum
mechanics. However, a reaction term could be added to the brain domain that would
describe uptake of glucose into brain cells. In addition, a capillary complete with a
blood-brain barrier could be created to replace the concentration boundary condition in
the symmetric model. This would allow the blood glucose concentration to be the
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boundary condition, which is more realistic than the outer wall of the blood-brain barrier
having a constant concentration.
One of the most useful implications for reverse microdialysis is in membrane
characterization. By running the probe in vitro, the environmental concentration is no
longer an unknown because fluid medium can be specifically made. Because the external
concentration is no longer an unknown, it is possible to solve for a different variable, i.e.
the membrane diffusion coefficient.. Experimentally, the probe would first need to be
run in vitro at a variety of solution and perfusate concentrations, recording the outlet
concentration each time. The model can then be easily adapted to in vitro by removing
the brain domain and setting the outer boundary of the membrane to the solution
concentration (assuming a well-mixed solution). Then the model could simply be run at
varying membrane diffusivities until the modeled outlet concentrations match
experimental results.
The model is useful in many other “what if” scenarios. For instance, the model
can be used to determine the highest flow rate possible without draining the brain glucose
to a critical level. It is known that as brains get older, the nominal glucose concentration
remains the same, but glucose diffusion through the brain slows down. Knowing all
other data, brain diffusivities can be back-calculated using this model. The model is
widely adaptable and simple to operate, and uses for the model will be far reaching.
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7.4

Taylor Dispersion

The effects of Taylor dispersion were investigated due to a lack of agreement in
the literature. One article concluded that dispersion was negligible, while another claimed
it to be the limiting factor in temporal resolution.26,27 The two papers had consistent
results but differing perspectives. Norton et al. was looking at large, long-lasting signals,
while Wang et al. was trying to precisely describe the short transient period during
concentration changes.
In the case presented here, time to steady-state degrades the signal nearly as much
as dispersion in the tubing, 60 s to 104 s, respectively. When working with awake,
freely-moving rats and long exit tubing is necessary, Taylor dispersion should not be
ignored.
The mfile was run at increasingly shorter tube lengths to determine at what point
dispersion is negligible. Even with a tube length of 0.1 m (a customary length for
anaesthetized rats), the signal is still degraded 12 s by dispersion. This could be
considered negligible for large scale brain functions, but as microdialysis techniques
improve and as researchers want to look at shorter and shorter brain functions, even
dispersion in short tubes will have to be considered.
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8.

Conclusion

In this thesis, I created a model based on first principles and well-founded
parameters that accurately describes a real microdialysis system. With this model, I was
able to show the validity of ZNF and the accompanying assumptions. I was also able to
prove that the ZNF slope is independent of brain concentration, a feature that is helpful in
practice. Furthermore, I determined that it takes approximately one minute for the probe
to reach steady-state after both startup and an environmental change. The model allowed
me to determine the sensitivity of results to each individual parameter, values that were
inaccessible experimentally. Using a separate model, I was able to show that the
perfusate is in thermal equilibrium with the brain throughout the active region of the
probe.
I quantified the extent of Taylor dispersion in probe exit tubing. For a two meter
tube, a common length for testing awake specimens, the dispersion time is around two
minutes. Signal degradation should not be thought of in the typical limiting factor sense
because the three factors that affect necessary signal time are additive, not competitive.
The sensitivity of the analytical instrument, the time to steady-state in the probe, and the
amount of dispersion in the tubing all compound to increase the length of the shortest
measurable thought. I designed a dimensionless number to help quantify this concept.
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Mass Balance

BC: Outlet

BC: No slip
u=0

Navier-Stokes
not solved for in
these domains

BC: Inlet- defined as a
laminar inflow and set using
volumetric flow rate

Boundary conditions for Stokes Creep Flow (Equation 3).
Model is not shown to scale.
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Mass Balance

BC: Outlet

BC: All other
external boundaries
are set as no flux

BC: Concentration- set
as constant uniform
concentration, defined
as average ECF glucose
concentration

BC: Inflow- set as a
constant concentration,
defined as the inlet
glucose concentration

Boundary conditions for Conservation of Mass Equation (Equation 4).
Model is not shown to scale.
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Mass Balance
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For those not familiar with COMSOL 4.2
Creating a CMA-12 Brain-Probe System
Open COMSOL 4.2
From the Model Wizard window, select 2D axisymmetric and press next (light blue
arrow)
From the Add Physics tree, select Fluid Flow>Single-Phase Flow>Creeping Flow (spf)
Click the Add Selected button at the bottom (light blue plus sign)
From the Add Physics tree, select Chemical Species Transport>Transport of Diluted
Species (chds)
Press the Add Selected button, the press next
From the Studies tree, select Preset Studies for Selected Physics>Stationary
Press Finish (checkered flag) to start modeling
In the Model Builder window, right-click Global Definitions and choose Parameters
Go to the Settings window for Parameters
In the Parameters table, enter the following settings (the name column is case sensitive)
Name
V
rhoP
etaP
c0P
c0B
cC
DP
DM
DB

Expression
1.67e-11 [m^3/s]
990 [kg/m^3]
7.28e-4 [kg/(m*s)]
0.5 [mol/m^3]
1.25 [mol/m^3]
1.25 [mol/m^3]
8.3e-10 [m^2/s]
7.62e-11 [m^2/s]
1.16e-10 [m^2/s]

Description (optional)
Volumetric flow rate, perfusate
Density, perfusate
Dynamic viscosity, perfusate
Initial concentration, perfusate
Initial concentration, brain
Concentration in sampling fluid
Diffusion coefficient, perfusate
Diffusion coefficient, membrane
Diffusion coefficient, brain

(If you intend to make any more models in the future, it may be beneficial to save your
parameters as a text file. You can do this by selecting the Save to file button (looks like a
floppy disk) located under the parameters table.)
Modeling the System
From the Model Builder window, select Geometry 1
In the Settings window for Geometry, change the Length Unit from m to µm
From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 85
Height: 3000
Base: Corner
r: 125
z: 0
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From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 40
Height: 3000
Base: Corner
r: 210
z: 0

From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 50
Height: 3025
Base: Corner
r: 250
z: -25
From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 300
Height: 50
Base: Corner
r: 0
z: -75
From the Model Builder window, right-click Geometry 1 and choose Boolean
Operation>Union
In the Graphics window, left-click on the right most rectangle (r3) (the domain should
turn red) and then right-click the same rectangle (the domain should turn blue and
is now added to the Input objects list in the Settings window). Repeat this step
for r4, the lowest rectangle.
The Input objects list should now contain: r3 and r4
Uncheck the Keep interior boundaries box
From the Model Builder window, select Form Union
In the Settings window for Finalize, select Build Selected (the light blue skyscraper with
red box, near the top)
In the Model Builder window, minimize the Geometry 1 menu (white downward arrow
head next to Geometry 1)
You now have a 2D representation of the brain-probe system that will produce accurate
results. The inner (left most) rectangle is the perfusate domain. Fluid will come in from
the bottom and exit to top. The middle rectangle is the membrane. And the backwards-L-
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shaped domain is the brain. When solving, COMSOL will “wrap” this 2D section
around the r=0 axis (red dashed line) to form a 3D cylinder. We can use the 2D
axisymmetric model because the system is angle independent. Now you will assign
domain and boundary conditions to the geometry.
Perfusate Settings
From the Model Builder window, select Creeping Flow
In the Settings window, use the control button on your keyboard to simultaneously select
the following Domains: 1, 3
Press the Remove from Selection button (light blue minus sign to the right of the
selection field)
You may have to scroll the Settings window over to see the button.
In the Settings window, under Physical Model, change Compressibility to
Incompressible flow
Expand the Creeping Flow menu by clicking the rightward facing arrow next to
Creeping Flow
From the Model Builder window, select Creeping Flow>Fluid Properties 1
In the Settings window, change Density to User defined and enter “rhoP” into the edit
field (do not include the quotation marks)
In the Settings window, change Dynamic viscosity to User defined and enter “etaP” into
the edit field
You have just assigned conditions of incompressible creep fluid flow to the probe. We do
not do this for the other parts of the model because the brain and membrane do not
contain fluid flow. The next step is assigning the boundary conditions governing the flow
of the perfusate.
From the Model Builder window, right-click Creeping Flow and select Inlet
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and
then right-click
In the Settings window, the Boundary Selection list should now contain: 5
In the Settings window, under Boundary Conditions, change Boundary Condition to
Laminar inflow
Under Laminar Inflow, select Flow rate and then enter “V” into the V0 edit field
Enter “0” into the Lentr edit field and select the box next to Constrain endpoints to zero
From the Model Builder window, right-click Creeping Flow and select Outlet
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the
right-click it
In the Settings window, the Boundary Selection list should now contain: 6
Minimize the Creeping Flow menu
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Expand the Transport of Diluted Species menu
From the Model Builder window, right-click Convection and Diffusion 1 and select
Rename
F2 is the shortcut key for renaming an item.
Change the name to Perfusate and press OK
In the Settings window, under Model Inputs, change the Velocity field to Velocity
Field (spf/fp1)
In the Settings window, under Diffusion, enter “DP” into the Diffusion coefficient edit
field
From the Model Builder window, right-click Initial Values 1 and select Rename
Change the name to Initial Perf/Memb Values and press OK
In the Settings window, under Initial, enter “c0P” into the Concentration edit field
From the Model Builder window, right-click Transport of Diluted Species and select
Inflow
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and
then right-click
In the Settings window, the Boundary Selection list should now contain: 5
In the Settings window, under Concentration, enter “c0P” into the c0,c edit field
From the Model Builder window, right-click Transport of Diluted Species and select
Outflow
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the
right-click it
In the Settings window, the Boundary Selection list should now contain: 6

Membrane Settings
From the Model Builder window, right-click Transport of Diluted Species and select
Convection and Diffusion
From the Model Builder window, right-click Convection and Diffusion 2 and select
Rename
Change the name to Membrane and press OK
In the Graphics window, left-click the middle rectangle (r2) and then right-click it
In the Settings window, the Boundary Selection list should now contain: 3
In the Settings window, under Diffusion, enter “DM” into the Diffusion coefficient edit
field
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Brian Settings
From the Model Builder window, right-click Transport of Diluted Species and select
Convection and Diffusion
From the Model Builder window, right-click Convection and Diffusion 3 and select
Rename
Change the name to Brain and press OK
In the Graphics window, left-click the backwards-L-shaped domain and then right-click
it
In the Settings window, the Boundary Selection list should now contain: 1
In the Settings window, under Diffusion, enter “DB” into the Diffusion coefficient edit
field
From the Model Builder window, right-click Transport of Diluted Species and select
Initial Values
From the Model Builder window, right-click Initial Values 2 and select Rename
Change the name to Initial Brain Values and press OK
In the Graphics window, left-click the backwards-L-shaped domain and then right-click
it
In the Settings window, the Boundary Selection list should now contain: 1
In the Settings window, under Initial, enter “c0B” into the Concentration edit field
From the Model Builder window, right-click Transport of Diluted Species and select
Concentration
In the Graphics window, alternatively left- and right-click the two right most and the
lowest boundary and then right-click them (the second right most boundary is
small and at the bottom)
In the Settings window, the Boundary Selection list should now contain: 2, 13 and 14
In the Settings window, under Concentration, select the box next to Species c and enter
“cC” into the c0,c edit field
Minimize the Transport of Diluted Species menu

Mesh
Now you have set up all the physics governing the system. Next, a mesh must be created
which COMSOL will solve the equations over and then solve the problem. Fortunately,
COMSOL has suggested meshes for certain physics and geometries. The suggestion
works for our case and is the default mesh; so you do not have to do anything.
From the Model Builder window, select Mesh 1
In the Settings window, make sure the Sequencing type reads Physics-controlled mesh
and the Element size is Normal
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Solving
From the Model Builder window, right-click Study 1 and select Parametric Sweep
In the Settings window, select the Add button (light blue plus sign)
Select c0P (Initial concentration, perfusate) from the list and press OK
In the Parameter Values edit field, enter the inlet concentrations you are using for the
ZNF method, separating each concentration by a space
For example, entering: “0.5 1 1.5 2” will tell COMSOL to run the model 4 times
with each run having one of the following inlet concentrations: 0.5 mM, 1.0 mM,
1.5 mM and 2.0 mM
From the toolbar, select Compute (green equal sign)

Postprocessing
COMSOL should automatically produce both 2D and 3D solutions which can be found in
the Results tab in the Model Builder. If they are not automatically produced, follow the
below directions as examples of possible result graphics.

To see the 2D velocity profile:
From the Model Builder window, right-click Results and select 2D Plot Group
From the Model Builder window, right-click 2D Plot Group 1 and select Rename
Change the name to Velocity and press OK
From the Model Builder window, right-click Velocity and select Surface
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Velocity menu
To see the 3D velocity profile:
From the Model Builder window, right-click Results and select 3D Plot Group
From the Model Builder window, right-click 3D Plot Group 1 and select Rename
Change the name to Velocity and press OK
From the Model Builder window, right-click Velocity and select Surface
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Velocity menu
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To see the 2D concentration profile:
From the Model Builder window, right-click Results and select 2D Plot Group
From the Model Builder window, right-click 2D Plot Group 1 and select Rename
Change the name to Concentration and press OK
From the Model Builder window, right-click Concentration and select Surface
In the Settings window, under Expression, select Replace Expression (green and
orange triangles)
Select Transport of Diluted Species>Species c>Concentration (c)
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Concentration menu
To see the 3D concentration profile:
From the Model Builder window, right-click Results and select 3D Plot Group
From the Model Builder window, right-click 3D Plot Group 1 and select Rename
Change the name to Concentration and press OK
From the Model Builder window, right-click Concentration and select Surface
In the Settings window, under Expression, select Replace Expression (green and
orange triangles)
Select Transport of Diluted Species>Species c>Concentration (c)
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Concentration menu
To change which value of c0P is shown (for any graphic):
From the Model Builder window, select Concentration
In the Settings window, under Data, select the desired c0P from the Parameter Value
drop down menu
In the Settings window, select Plot (rainbow pencil near top)
To find the concentration of glucose at the outlet of the Perfusate:
From the Model Builder window, right-click Results>Derived Values and select
Average>Line Average
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the
right-click it
In the Settings window, the Boundary Selection list should now contain: 6
In the Settings window, under Expression, select Replace Expression (green and
orange triangles)
Select Transport of Diluted Species>Species c>Concentration (c)
Select Evaluate (New Table) (orange equal sign at top)
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Creating a CMA-12 Brain Probe
Space Dimension: 2D axisymmetric
Physics: Creeping Flow (spf), Transport of Diluted Species (chds)
Study: Stationary (Preset for Selected Physics)
Parameters
Add these under global definitions
Name
V
rhoP
etaP
c0P
c0B
cC
DP
DM
DB

Expression
1.67e-11 [m^3/s]
990 [kg/m^3]
7.28e-4 [kg/(m*s)]
0.5 [mol/m^3]
1.25 [mol/m^3]
1.25 [mol/m^3]
8.3e-10 [m^2/s]
7.62e-11 [m^2/s]
1.16e-10 [m^2/s]

Description (optional)
Volumetric flow rate, perfusate
Density, perfusate
Dynamic viscosity, perfusate
Initial concentration, perfusate
Initial concentration, brain
Concentration in sampling fluid
Diffusion coefficient, perfusate
Diffusion coefficient, membrane
Diffusion coefficient, brain

Geometry
Length Unit: μm
Geometries:
Perfusate (r1)
Shape: rectangle
Width: 85
Height: 3000
Base: Corner
r: 125
z: 0

Membrane (r2)
Shape: rectangle
Width: 40
Height: 3000
Base: Corner
r: 210
z: 0

Side of Brain (r3)
Shape: rectangle
Width: 50
Height: 3025
Base: Corner
r: 250
z: -25

Bottom of Brain (r4)
Shape: rectangle
Width: 300
Height: 50
Base: Corner
r: 0
z: -75

Create a Boolean Union between r3 and r4. Do NOT keep Interior Boundaries
Finalize the geometry with Form a Union

Appendix D

89

For those familiar with COMSOL 4.2
Physics
Creeping Flow (domain 2):
Compressibility: Incompressible flow
Fluid Properties:
Density: User defined: “rhoP”
Dynamic viscosity: User defined: “etaP”
Inlet (boundary 5):
Boundary Condition: Laminar Inlow
Laminar Inflow: Flow rate
Flow rate: “V”
Entrance length: “0”
Constrain endpoints to zero: √
Outlet (boundary 6):
Boundary Condition: Pressure, no viscous stress
Pressure: “0”
Transport of Diluted Species (domains 1,2,3)
Convection: √
Convection and Diffusion 1:
Velocity field: Velocity field (spf/fp1)
Diffusion coefficient: User defined: “DP”
Initial Values 1:
Concentration: “c0P”
Inflow 1 (boundary 5):
c0,c: “c0P”
Outflow 1 (boundary 6)
Convection and Diffusion 2 (domain 3):
Velocity field: “0” r
“0”
z
Diffusion coefficient: User defined: “DM”
Convection and Diffusion 3 (domain 1):
Velocity field: “0” r
“0”
z
Diffusion coefficient: User defined: “DB”
Initial Values 2 (domain 1):
Concentration: “c0B”
Concentration 1 (boundaries 2,13,14):
Species c: √
c0,c: “cC”

B-89
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Mesh
Sequence type: Physics-controlled mesh
Element size: Normal

Solving
If using model for ZNF, use a Parametric Sweep to vary c0P

Postprocessing
COMSOL should automatically plot 2D and 2D results for both velocity and
concentration.
To determine outlet analyte concentration:
Select the following boundary: 6
Create a Line Average from Results>Derived Values>Averages
Change the Expression to Transport of Diluted Species>Species c>Concentration (c)
.

B-90
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Creating a Microdialysis Probe
This is to be used when you are working with a probe that has the same basic structure as
the CMA-12 but different dimensions, ie. a CMA-10
These instructions are to be used in conjunction with another instruction. Start in the
other instructions, set up the basic physics, and when you get to the Parameters section,
start here.
Parameters
Add these under global definitions. The following values are for a CMA-12 probe and
should be adjusted for the appropriate system.
Name
V
rhoP
etaP
c0P
c0B
cC
DP
DM
DB
wa
hM
off
wM

Expression
1.67e-11 [m^3/s]
990 [kg/m^3]
7.28e-4 [kg/(m*s)]
0.5 [mol/m^3]
1.25 [mol/m^3]
1.25 [mol/m^3]
8.3e-10 [m^2/s]
7.62e-11 [m^2/s]
1.16e-10 [m^2/s]
8.5e-5 [m]
.003 [m]
1.25e-4 [m]
4e-5 [m]

Description (optional)
Volumetric flow rate, perfusate
Density, perfusate
Dynamic viscosity, perfusate
Initial concentration, perfusate
Initial concentration, brain
Concentration in sampling fluid
Diffusion coefficient, perfusate
Diffusion coefficient, membrane
Diffusion coefficient, brain
Width of annulus, active region of probe
Membrane height
Distance inner wall of annulus if from center of probe
Membrane width

Geometry
Length Unit: μm
Geometries:
Perfusate (r1)
Membrane (r2)
Side of Brain (r3)
Bottom of Brain (r4)
Shape: rectangle Shape: rectangle
Shape: rectangle
Shape: rectangle
Width: wa
Width: wM
Width: wB
Width: off+wa+wM+wB
Height: hM
Height: hM
Height: wB+base
Height: wB
Base: Corner
Base: Corner
Base: Corner
Base: Corner
x: off
x: off+wa
x: off+wa+wM
x: 0
y: 0
y: 0
y: -base
y: -base-wB
Create a Boolean Union between r3 and r4. Do NOT keep Interior Boundaries
Finalize the geometry with Form a Union
Now continue with the other instructions starting at Perfusate Settings
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Sensitivity Analysis Data
Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Outlet Glucose Concentration (mM)

Inlet Flow Rate
% off norm

V (m3/s)

Co (mM)

% c off norm

10
50
67
91
95
99
100
101
105
110
150
200
1000

1.67E-12
8.35E-12
1.12E-11
1.52E-11
1.59E-11
1.65E-11
1.67E-11
1.69E-11
1.75E-11
1.84E-11
2.51E-11
3.34E-11
1.67E-10

1.196371648
0.819496487
0.754872636
0.697953383
0.690837086
0.684213152
0.682628216
0.681070261
0.675095027
0.668157966
0.627697607
0.598220227
0.521500262

175.3
120.1
110.6
102.2
101.2
100.2
100.0
99.8
98.9
97.9
92.0
87.6
76.4

1.40
1.20
1.00
0.80
0.60
0.40
0.20
0.00

Volumetric Flow Rate (m3/s)
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Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Brain Width
% off norm

Outlet Glucose Concentration (mM)

10
50
67
91
95
99
0
101
105
110
150
200
1000

wB (µm)

5.0
25.0
33.5
45.5
47.5
49.5
50.0
50.5
52.5
55.0
75.0
100.0
500.0

Co (mM)

% c off norm

0.760106855
0.71727512
0.703741017
0.687821859
0.685466335
0.68318767
0.682628223
0.682095834
0.679913196
0.677261851
0.659318232
0.642652459
0.571224998

111.4
105.1
103.1
100.8
100.4
100.1
100.0
99.9
99.6
99.2
96.6
94.1
83.7

0.800
0.700
0.600
0.500
0.400
0.300
0.200
0.100
0.000
0

100

200

300
Brain Width (μm)

400

500

600
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Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Diffusion Coefficient in Brain
% off norm

Outlet Glucose Concentration (mM)

10
50
67
91
95
99
0
101
105
110
150
200
1000

DB (m2/s)

1.16E-11
5.80E-11
7.77E-11
1.06E-10
1.10E-10
1.15E-10
1.16E-10
1.17E-10
1.22E-10
1.28E-10
1.74E-10
2.32E-10
1.16E-09

Co (mM)

% c off norm

0.545311844
0.636711234
0.656719474
0.67676442
0.679460428
0.68201167
0.682628216
0.683236593
0.685591572
0.688369632
0.705589725
0.719357181
0.761218841

79.9
93.3
96.2
99.1
99.5
99.9
100.0
100.1
100.4
100.8
103.4
105.4
111.5

0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
0.00
0.00E+00

2.00E-10

4.00E-10

6.00E-10

8.00E-10

1.00E-09

Diffusion Coefficient in Brain (m2/s)

1.20E-09

1.40E-09
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Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Diffusion Coefficient in Membrane
% off norm

Outlet Glucose Concentration (mM)

10
50
67
91
95
99
0
101
105
110
150
200
1000

DM (m2/s)

7.62E-12
3.81E-11
5.11E-11
6.93E-11
7.24E-11
7.54E-11
7.62E-11
7.70E-11
8.00E-11
8.38E-11
1.14E-10
1.52E-10
7.62E-10

Co (mM)

% c off norm

0.53357684
0.622428341
0.647126927
0.674121608
0.67804422
0.6816836
0.682629269
0.683564803
0.686985485
0.691129452
0.718040094
0.741566103
0.824792021

78.2
91.2
94.8
98.8
99.3
99.9
100.0
100.1
100.6
101.2
105.2
108.6
120.8

0.90
0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
0.00
0.00E+00 1.00E-10 2.00E-10 3.00E-10 4.00E-10 5.00E-10 6.00E-10 7.00E-10 8.00E-10 9.00E-10
Diffusion Coefficient in Membrane (m 2/s)
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Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Diffusion Coefficient in Perfusate
% off norm

Outlet Glucose Concentration (mM)

10
50
67
91
95
99
0
101
105
110
150
200
1000

DP (m2/s)

8.30E-11
4.15E-10
5.56E-10
7.55E-10
7.89E-10
8.22E-10
8.30E-10
8.38E-10
8.72E-10
9.13E-10
1.25E-09
1.66E-09
8.30E-09

Co (mM)

% c off norm

0.644430147
0.676519387
0.679560704
0.682005735
0.68229671
0.682564558
0.682628216
0.682690626
0.682928469
0.683201525
0.684721967
0.68573044
0.68626844

94.4
99.1
99.6
99.9
100.0
100.0
100.0
100.0
100.0
100.1
100.3
100.5
100.5

0.690
0.685
0.680
0.675
0.670
0.665
0.660
0.655
0.650
0.645
0.640
0.00E+00 1.00E-09 2.00E-09 3.00E-09 4.00E-09 5.00E-09 6.00E-09 7.00E-09 8.00E-09 9.00E-09
Perfusate Diffusivity (m^2/s)
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Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Perfusate Density
% off norm

Outlet Glucose Concentration (mM)

10
50
67
91
95
99
0
101
105
110
150
200
1000

rhoP (kg/m3)

99.0
495.0
663.3
900.9
940.5
980.1
990.0
999.9
1039.5
1089.0
1485.0
1980.0
9900.0

Co (mM)

% c off norm

0.682628223
0.682628195
0.682628026
0.682628058
0.682628203
0.682628215
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216

100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0

0.683
0.683
0.683
0.683
0.683
0.683
0

1000

2000

3000

4000

5000

6000

Density (kg/m^3)

7000

8000

9000

10000
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Sensitivity Analysis Data
Sensitivity Data

In all analyses, Cin = 0.5 mM
Sensitivity of Outlet Glucose Concentration to:

Perfusate Viscosity
% off norm

Outlet Glucose Concentration (mM)

10
50
67
91
95
99
0
101
105
110
150
200
1000

etaP (Pa*s)

7.28E-05
3.64E-04
4.88E-04
6.62E-04
6.92E-04
7.21E-04
7.28E-04
7.35E-04
7.64E-04
8.01E-04
1.09E-03
1.46E-03
7.28E-03

Co (mM)

% c off norm

0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216
0.682628216

100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0

0.683
0.683
0.683
0.683
0.683
0.683
0.683
0.683
0.683
0.00E+00 1.00E-03 2.00E-03 3.00E-03 4.00E-03 5.00E-03 6.00E-03 7.00E-03 8.00E-03
Dynamic Viscosity (Pa*s)
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Transient Model
Creating a Transient CMA-12 Brain-Probe System
For those not familiar with COMSOL 4.2
Open COMSOL 4.2
From the Model Wizard window, select 2D axisymmetric and press next (light blue
arrow)
From the Add Physics tree, select Fluid Flow>Single-Phase Flow>Creeping Flow (spf)
Click the Add Selected button at the bottom (light blue plus sign)
From the Add Physics tree, select Chemical Species Transport>Transport of Diluted
Species (chds)
Press the Add Selected button, the press next
From the Studies tree, select Preset Studies for Selected Physics>Time Dependent
Press Finish (checkered flag) to start modeling
In the Model Builder window, right-click Global Definitions and choose Parameters
Go to the Settings window for Parameters
In the Parameters table, enter the following settings (the name column is case sensitive)
Name
V
rhoP
etaP
c0P
c0B
cC
DP
DM
DB

Expression
1.67e-11 [m^3/s]
990 [kg/m^3]
7.28e-4
[kg/(m*s)]
0.5 [mol/m^3]
1.25 [mol/m^3]
1.25 [mol/m^3]
8.3e-10 [m^2/s]
7.62e-11 [m^2/s]
1.16e-10 [m^2/s]

Description (optional)
Volumetric flow rate, perfusate
Density, perfusate
Dynamic viscosity, perfusate
Initial concentration, perfusate
Initial concentration, brain
Concentration in sampling fluid
Diffusion coefficient, perfusate
Diffusion coefficient, membrane
Diffusion coefficient, brain

(If you intend to make any more models in the future, it may be beneficial to save your
parameters as a text file. You can do this by selecting the Save to file button (looks like a
floppy disk) located under the parameters table.)
In the Model Builder window, right-click Global Definitions and choose
Functions>Piecewise
From the Model Builder window, right-click Piecewise 1 (pw1) and select Rename
F2 is the shortcut key for renaming an item.
Change the name to Vstep and press OK
From the Model Builder window, select Vstep (pw1)
In the Settings window, under Function, enter “Vstep” into the Function name edit
field
In the Settings window, under Parameters, enter “t” into the Argument edit field
In the Settings window, under Parameters, change Smoothing to Continuous Function
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In the Settings window, under Parameters, enter “0.01” into the Relative Size of
Transition Zone edit field
In the Settings window, under Parameters, enter the following into the Intervals table
Start
0
0.01

End
0.01
1000

Function
0
V

This creates the initial ramping up of the perfusate flow.
In the Model Builder window, right-click Global Definitions and choose
Functions>Piecewise
From the Model Builder window, right-click Piecewise 2 (pw2) and select Rename
Change the name to cBstep and press OK
From the Model Builder window, select cBstep (pw2)
In the Settings window, under Function, enter “cBstep” into the Function name edit
field
In the Settings window, under Parameters, enter “t” into the Argument edit field
In the Settings window, under Parameters, change Smoothing to Continuous Function
In the Settings window, under Parameters, enter “0.01” into the Relative size of
transition zone edit field
In the Settings window, under Parameters, enter the following into the Intervals table
Start
0
250
500

End
250
500
1000

Function
c0B
1
c0B

This creates a step function in the brain concentration. The “dip” constitutes a thought,
i.e. more glucose is being consumed.
Modeling the System
From the Model Builder window, select Geometry 1
In the Settings window for Geometry, change the Length Unit from m to µm
From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 85
Height: 3000
Base: Corner
r: 125
z: 0

Appendix G

101

Transient Model
From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 40
Height: 3000
Base: Corner
r: 210
z: 0
From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 50
Height: 3025
Base: Corner
r: 250
z: -25
From the Model Builder window, right-click Geometry 1 and choose Rectangle
In the Settings window for Rectangle, enter the following dimensions:
Width: 300
Height: 50
Base: Corner
r: 0
z: -75
From the Model Builder window, right-click Geometry 1 and choose Boolean
Operation>Union
In the Graphics window, left-click on the right most rectangle (r3) (the domain should
turn red) and then right-click the same rectangle (the domain should turn blue and
is now added to the Input objects list in the Settings window). Repeat this step
for r4, the lowest rectangle.
The Input objects list should now contain: r3 and r4
Uncheck the Keep interior boundaries box
From the Model Builder window, select Form Union
In the Settings window for Finalize, select Build Selected (the light blue skyscraper with
red box, near the top)
In the Model Builder window, minimize the Geometry 1 menu (white downward arrow
head next to Geometry 1)
You now have a 2D representation of the brain-probe system that will produce accurate
results. The inner (left most) rectangle is the perfusate domain. Fluid will come in from
the bottom and exit to top. The middle rectangle is the membrane. And the backwards-Lshaped domain is the brain. When solving, COMSOL will “wrap” this 2D section
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around the r=0 axis (red dashed line) to form a 3D cylinder. We can use the 2D
axisymmetric model because the system is angle independent. Now you will assign
domain and boundary conditions to the geometry.
Perfusate Settings
From the Model Builder window, select Creeping Flow
In the Settings window, use the control button on your keyboard to simultaneously select
the following Domains: 1, 3
Press the Remove from Selection button (light blue minus sign to the right of the
selection field)
You may have to scroll the Settings window over to see the button.
In the Settings window, the Domain Selection list should now contain: 2
In the Settings window, under Physical Model, change Compressibility to
Incompressible flow
Expand the Creeping Flow menu by clicking the rightward facing arrow next to
Creeping Flow
From the Model Builder window, select Creeping Flow>Fluid Properties 1
In the Settings window, change Density to User defined and enter “rhoP” into the edit
field (do not include the quotation marks)
In the Settings window, change Dynamic viscosity to User defined and enter “etaP” into
the edit field
You have just assigned conditions of incompressible creep fluid flow to the probe. We do
not do this for the other parts of the model because the brain and membrane do not
contain fluid flow. The next step is assigning the boundary conditions governing the flow
of the perfusate.
From the Model Builder window, right-click Creeping Flow and select Inlet
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and
then right-click
In the Settings window, the Boundary Selection list should now contain: 5
In the Settings window, under Boundary Conditions, change Boundary Condition to
Laminar inflow
Under Laminar Inflow, select Flow rate and then enter “Vstep(t)” into the V0 edit field
The entry will remain orange, that is OK.
Enter “0” into the Lentr edit field and select the box next to Constrain endpoints to zero
From the Model Builder window, right-click Creeping Flow and select Outlet
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the
right-click it
In the Settings window, the Boundary Selection list should now contain: 6
Minimize the Creeping Flow menu
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Expand the Transport of Diluted Species menu
From the Model Builder window, right-click Convection and Diffusion 1 and select
Rename
Change the name to Perfusate and press OK
In the Settings window, under Model Inputs, change the Velocity field to Velocity
Field (spf/fp1)
In the Settings window, under Diffusion, enter “DP” into the Diffusion coefficient edit
field
From the Model Builder window, right-click Initial Values 1 and select Rename
Change the name to Initial Perf/Memb Values and press OK
In the Settings window, under Initial, enter “c0P” into the Concentration edit field
From the Model Builder window, right-click Transport of Diluted Species and select
Inflow
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and
then right-click
In the Settings window, the Boundary Selection list should now contain: 5
In the Settings window, under Concentration, enter “c0P” into the c0,c edit field
From the Model Builder window, right-click Transport of Diluted Species and select
Outflow
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the
right-click it
In the Settings window, the Boundary Selection list should now contain: 6

Membrane Settings
From the Model Builder window, right-click Transport of Diluted Species and select
Convection and Diffusion
From the Model Builder window, right-click Convection and Diffusion 2 and select
Rename
Change the name to Membrane and press OK
In the Graphics window, left-click the middle rectangle (r2) and then right-click it
In the Settings window, the Boundary Selection list should now contain: 3
In the Settings window, under Diffusion, enter “DM” into the Diffusion coefficient edit
field
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Brian Settings
From the Model Builder window, right-click Transport of Diluted Species and select
Convection and Diffusion
From the Model Builder window, right-click Convection and Diffusion 3 and select
Rename
Change the name to Brain and press OK
In the Graphics window, left-click the backwards-L-shaped domain and then right-click
it
In the Settings window, the Boundary Selection list should now contain: 1
In the Settings window, under Diffusion, enter “DB” into the Diffusion coefficient edit
field
From the Model Builder window, right-click Transport of Diluted Species and select
Initial Values
From the Model Builder window, right-click Initial Values 2 and select Rename
Change the name to Initial Brain Values and press OK
In the Graphics window, left-click the backwards-L-shaped domain and then right-click
it
In the Settings window, the Boundary Selection list should now contain: 1
In the Settings window, under Initial, enter “c0B” into the Concentration edit field
From the Model Builder window, right-click Transport of Diluted Species and select
Concentration
In the Graphics window, alternatively left- and right-click the two right most and the
lowest boundary and then right-click them (the second right most boundary is
small and at the bottom)
In the Settings window, the Boundary Selection list should now contain: 2, 13 and 14
In the Settings window, under Concentration, select the box next to Species c and enter
“cBstep(t)” into the c0,c edit field
The entry will remain orange, that is OK.
Minimize the Transport of Diluted Species menu
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Mesh
Now you have set up all the physics governing the system. Next, a mesh must be created
which COMSOL will solve the equations over and then solve the problem. Fortunately,
COMSOL has suggested meshes for certain physics and geometries. The suggestion
works for our case and is the default mesh; so you do not have to do anything.
From the Model Builder window, select Mesh 1
In the Settings window, make sure the Sequencing type reads Physics-controlled mesh
and the Element size is Normal

Solving
In the Settings window, under Study Settings, enter “range(0,1,750)” into the Times edit
field
From the toolbar, select Compute (green equal sign)
Postprocessing
COMSOL should automatically produce both 2D and 3D solutions which can be found in
the Results tab in the Model Builder. If they are not automatically produced, follow the
below directions as examples of possible result graphics.
To see the 2D velocity profile:
From the Model Builder window, right-click Results and select 2D Plot Group
From the Model Builder window, right-click 2D Plot Group 1 and select Rename
Change the name to Velocity and press OK
From the Model Builder window, right-click Velocity and select Surface
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Velocity menu
To see the 3D velocity profile:
From the Model Builder window, right-click Results and select 3D Plot Group
From the Model Builder window, right-click 3D Plot Group 1 and select Rename
Change the name to Velocity and press OK
From the Model Builder window, right-click Velocity and select Surface
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Velocity menu
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To see the 2D concentration profile:
From the Model Builder window, right-click Results and select 2D Plot Group
From the Model Builder window, right-click 2D Plot Group 1 and select Rename
Change the name to Concentration and press OK
From the Model Builder window, right-click Concentration and select Surface
In the Settings window, under Expression, select Replace Expression (green and
orange triangles)
Select Transport of Diluted Species>Species c>Concentration (c)
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Concentration menu
To see the 3D concentration profile:
From the Model Builder window, right-click Results and select 3D Plot Group
From the Model Builder window, right-click 3D Plot Group 1 and select Rename
Change the name to Concentration and press OK
From the Model Builder window, right-click Concentration and select Surface
In the Settings window, under Expression, select Replace Expression (green and
orange triangles)
Select Transport of Diluted Species>Species c>Concentration (c)
In the Settings window, select Plot (rainbow and pencil at top)
Minimize the Concentration menu
To change which value of c0P is shown (for any graphic):
From the Model Builder window, select Concentration
In the Settings window, under Data, select the desired c0P from the Parameter Value
drop down menu
In the Settings window, select Plot (rainbow pencil near top)
To find the concentration of glucose at the outlet of the Perfusate:
From the Model Builder window, right-click Results>Derived Values and select
Average>Line Average
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the
right-click it
In the Settings window, the Boundary Selection list should now contain: 6
In the Settings window, under Expression, select Replace Expression (green and
orange triangles)
Select Transport of Diluted Species>Species c>Concentration (c)
Select Evaluate (New Table) (orange equal sign at top)
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Modeling Taylor Dispersion in MATLAB
%Damon Vinciguerra
clc
clear all
close all
home

Thesis

%% General Parameters
V = 1.67e-11;
L = 2;
R = 0.0001075;
eta = 7.28e-4;
D = 8.3e-10;
perfusate
vzavg = V/(pi*R^2);

%
%
%
%
%

Taylor Dispersion

m^3/s, Volumetric flow rate of dialysate
m, Lenght of tubing
m, inner radius of tubing
Pa*s, viscosity of perfusate
m^2/s, diffusivity of glucose through

% m/s, Velocity of dialysate

K = D+((R*vzavg)^2)/(48*D);
Re = vzavg*2*R*990/eta;
Per = R*vzavg/D;
Pea = L*vzavg/K;

%
%
%
%

m^2/s, mass transfer coefficient
Reynolds number
Peclet number, radial
Peclet number, axial

%% Domains - Boltzmann Sigmoidal
ex = 1000;
% s, Excess on ends to cusion test
tth = 250;
% s, Duration of thought
tfin = ex + tth + ex;
% s, Total time of simulation
ts = 100000;
% Time steps
tD = linspace(0,tfin/2+1,ts/2);
% s, Domain for concnetration drop
dt = tD(2)-tD(1);
tI = linspace(tfin/2+dt,tfin,ts/2); % s, Domain for concentration
increase
t = [tD tI];
Dt50 = ex ;
% s, Time at which drop is half way betwen T
and B
It50 = ex + tth;
% s, Time at which increase is half way
betwen B and T
z1 = Dt50*vzavg;
z2 = It50*vzavg;
tout=L/vzavg;
%% Signal - Boltzmann Sigmoidal Approximation
T = 0.6826;
% mM, Upper limit (Normal dialysate
concentration)
B = 0.6217;
% mM, Lower limit (Affected dialysate
concntration)
m = 6.6;
% mM/s, slope at t50
xD = B+((T-B)./(1+exp((Dt50-tD)./-m)));
xI = B+((T-B)./(1+exp((It50-tI)./m)));
dincrease
x = [xD xI];
subplot(2,2,1)

% mM, Signal for drop
% mM, Signal for
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plot(t,x)
ylabel('x(t)','FontSize',12)
xlabel('Time (s)','FontSize',12)
title('Signal: x(t)','FontSize',12)
axis([0 tfin .6 .7])
%% Smearing function: (1/sqrt(4*pi*k*t))*exp(L)
sig2 = 2.*K.*tout;
% Square of standard deviation
sig = sqrt(sig2);
% Standard deviation
Ng = 1001;
N = (Ng-1)/2;
dy = 10*sig/Ng;
% Number of points to trace out the curve (+/5*sig)
zf = dy*(-N:N);
% time base for smearing
function
f = exp(-((-zf).^2)./(2.*sig2))./sqrt(2.*pi.*sig2);
% smearing
function, Normal Distribution
subplot(2,2,2)
plot(zf,f)
xlabel('z-y','FontSize',12)
ylabel('f(z)','FontSize',12)
title('Smearing function: f(z)','FontSize',12)
%%
Nz
zz
mz

Compute convolution - Boltzmann Sigmoidal
= round(vzavg*tfin/dy);
= dy*(0:Nz);
= m*vzavg;
% mM/m, slope at t50

zzD = zz(1:floor(end/2));
zzI = zz(floor(end/2)+1:end);
xsD = B+((T-B)./(1+exp((z1-zzD)./-mz)));
xsI = B+((T-B)./(1+exp((z2-zzI)./mz)));
dincrease
xs = [xsD xsI];

% mM, Signal for drop
% mM, Signal for

xc = conv(xs,f,'full');
% Convolution of signal with smearing
function
tc = dy*(0:length(xc)-1);
tau = dy*length(f)/2;
% offset for filter width
g = (tc-tau)./vzavg;
y = xc/max(xc)*max(x);
subplot(2,1,2)
plot(t,x,'b',g(2*N:end-(2*N-1)),y(2*N:end-(2*N-1)),'--r')
axis([0 tfin .6 .7])
ylabel('y(t)','FontSize',12)
xlabel('Time (s)','FontSize',12)
title('Output signal: y(t) = f(z/v)*x(t)','FontSize',12)
legend('Signal','Output','Location','SouthEast')
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%% Width of dispersion in signal
er = 0.1;
% Allowable deviation from steady state
if min(x) < B + (T-B)*er
sigD = T;
k = 0;
while sigD > T - (T-B)*er
k = k + 1;
sigD = xD(k);
end
tDsT = tD(k);
while sigD > B + (T-B)*er
k = k + 1;
sigD = xD(k);
end
tDsB = tD(k);
wsig = tDsB - tDsT;
% Width of signal change
disp(['width of signal- ',num2str(wsig),' s (',num2str(wsig/60),'
min)'])
else
sigD = T;
k = 0;
while sigD > T - (T-B)*er
k = k + 1;
sigD = xD(k);
end
tDsT = tD(k);
tDsB = tfin/2;
wsig = tDsB - tDsT;
% Width of signal change
disp(['width of signal- ',num2str(wsig),' s (',num2str(wsig/60),'
min)'])
end
%% Width of Output
if min(y(2*N:end-(2*N-1))) < B + (T-B)*er
testD = T;
k = 2*N;
while testD > T - (T-B)*er
k = k + 1;
testD = y(k);
end
tDoT = g(k);
while testD > B + (T-B)*er
k = k + 1;
testD = y(k);
end
tDoB = g(k);
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wout = tDoB - tDoT;
% Width of output
disp(['Width of Output- ',num2str(wout),' s (',num2str(wout/60),'
min)'])
else
testD = T;
k = 2*N;
while testD > T - (T-B)*er
k = k + 1;
testD = y(k);
end
tDoT = g(k);
tDoB = tfin/2;
wout = tDoB - tDoT;
% Width of output
disp(['Width of Output- ',num2str(wout),' s (',num2str(wout/60),'
min)'])
end
%% Extent of Broadening
disp(' ')
disp(['Increase in width- ',num2str(wout-wsig),' s (',num2str((woutwsig)/60),' min)'])
%% Describing Broadenings
mTextBox = uicontrol('style','text');
set(mTextBox,'String',['Width- ',num2str(wsig),'
s'],'Position',[99,256,150,17],'FontSize',10)
nTextBox = uicontrol('style','text');
set(nTextBox,'String',['Width- ',num2str(wout),'
s'],'Position',[80,55,150,17],'FontSize',10)
%% Fitting Output
[coeffD,rD] = fit(g(2*N:floor(end/2))',y(2*N:floor(end/2))','a + (b a) ./ (1 + exp((h - x)/m))','start',[0.62 0.68 1100 -6.6]);
[coeffI,rI] = fit(g(floor(end/2)+1:end-(2*N-1))',y(floor(end/2)+1:end(2*N-1))','a + (b - a) ./ (1 + exp((h - x)/m))','start',[0.62 0.68 1900
6.6]);
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Plotting Dispersion Along Length of Tubing in MATLAB
%Damon Vinciguerra
clc
clear all
close all
home

Thesis

%% General Parameters
V = 1.67e-11;
R = 0.0001075;
eta = 7.28e-4;
D = 8.3e-10;
perfusate
vzavg = V/(pi*R^2);

Taylor Dispersion

% m^3/s, Volumetric flow rate of dialysate
% m, inner radius of tubing
% Pa*s, viscosity of perfusate
% m^2/s, diffusivity of glucose through
% m/s, Velocity of dialysate

K = D+((R*vzavg)^2)/(48*D);
Re = vzavg*2*R*990/eta;
Per = R*vzavg/D;

% mass transfer coefficient
% Reynolds number
% Peclet number, radial

%% Domains - Boltzmann Sigmoidal
ex = 1000;
% s, Excess on ends to cusion test
tth = 250;
% s, Duration of thought
tfin = ex + tth + ex;
% s, Total time of simulation
ts = 100000;
% Time steps
tD = linspace(0,tfin/2+1,ts/2);
% s, Domain for concnetration drop
dt = tD(2)-tD(1);
tI = linspace(tfin/2+dt,tfin,ts/2); % s, Domain for concentration
increase
t = [tD tI];
Dt50 = ex ;
% s, Time at which drop is half way betwen T
and B
It50 = ex + tth;
% s, Time at which increase is half way
betwen B and T
z1 = Dt50*vzavg;
z2 = It50*vzavg;
%% Signal - Boltzmann Sigmoidal Approximation
T = 0.6826;
% mM, Upper limit (Normal dialysate
concentration)
B = 0.6217;
% mM, Lower limit (Affected dialysate
concntration)
m = 6.6;
% mM/s, slope at t50
xD = B+((T-B)./(1+exp((Dt50-tD)./-m)));
xI = B+((T-B)./(1+exp((It50-tI)./m)));
dincrease
x = [xD xI];
%%
o = 0;
for L = 0.01:0.01:2
o = o + 1;

% mM, Signal for drop
% mM, Signal for
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%% Smearing function: (1/sqrt(4*pi*k*t))*exp(L)
tout=L/vzavg;
sig2 = 2.*K.*tout;
% Square of standard deviation
sig = sqrt(sig2);
% Standard deviation
Ng = 1001;
N = (Ng-1)/2;
dy = 10*sig/Ng;
% Number of points to trace out the curve (+/5*sig)
zf = dy*(-N:N);
% time base for
smearing function
f = exp(-((-zf).^2)./(2.*sig2))./sqrt(2.*pi.*sig2);
% smearing
function, Normal Distribution
%%
Nz
zz
mz

Compute convolution - Boltzmann Sigmoidal
= round(vzavg*tfin/dy);
= dy*(0:Nz);
= m*vzavg;
% mM/m, slope at t50

zzD = zz(1:floor(end/2));
zzI = zz(floor(end/2)+1:end);
xsD = B+((T-B)./(1+exp((z1-zzD)./-mz)));

% mM, Signal for

drop
xsI = B+((T-B)./(1+exp((z2-zzI)./mz)));
dincrease
xs = [xsD xsI];

% mM, Signal for

xc = conv(xs,f,'full');
% Convolution of signal with
smearing function
tc = dy*(0:length(xc)-1);
tau = dy*length(f)/2;
% offset for filter width
g = (tc-tau)./vzavg;
y = xc/max(xc)*max(x);
%% Width of Dispersion
er = 0.001;
state

% Allowable deviation from steady

if min(y(2*N:end-(2*N-1))) < B + (T-B)*er
testD = T;
k = 2*N;
while testD > T - (T-B)*er
k = k + 1;
testD = y(k);
end
tDoT = g(k);
while testD > B + (T-B)*er
k = k + 1;
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testD = y(k);
end
tDoB = g(k);
wdis(o) = tDoB - tDoT;

% Width of output

else
testD = T;
k = 2*N;
while testD > T - (T-B)*er
k = k + 1;
testD = y(k);
end
tDoT = g(k);
wdis(o) = tfin/2 - tDoT;
end
%% Width of Readable Signal
if min(y(2*N:end-(2*N-1))) < B + (T-B)*er
testS = T;
k = 2*N;
while testS > B + (T-B)*er
k = k + 1;
testS = y(k);
end
tSoU = g(k);
k = k + 1;
while testS < B + (T-B)*er
k = k + 1;
testS = y(k);
end
tSoB = g(k);
wsig(o) = tSoB - tSoU;

% Width of output

else
wsig(o) = 0;
end
%% Plotting
plot(t,x,'--b',g(2*N:end-(2*N-1)),y(2*N:end-(2*N-1)),'r')
axis([0 tfin .6 .7])
ylabel('Concentration (mM)','FontSize',12)
xlabel('Time (s)','FontSize',12)
title('Comparison of Output (-) to Signal (- -)','FontSize',12)
format short
nTextBox = uicontrol('style','text');
set(nTextBox,'String',['Distance Along Tube- ',num2str(L,3),' m
','Width of Deviation- ',num2str(wsig(o)/60),'
min'],'Position',[200,55,180,34],'FontSize',10)
drawnow
end
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title('Comparison of Output to Signal','FontSize',12)
legend('Signal','Output')
figure(2)
plot(0.005:0.005:1,wsig./tth)
title('Width of True Signal Concentration over Tube Length')
xlabel('Length of Tubing (%)')
ylabel('Width of Signal (% of initial)')
figure(3)
plot(0.005:0.005:1,wdis)
title('Dispersion of Signal "Step" over Length of Tubing')
xlabel('Length of Tubing (%)')
ylabel('Extent of Broadening (s)')
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Data for the Vinciguerra number
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Data for the Vinciguerra number

/1000
/500
/200
/100
/50
/40
/30
/20
/10
/5
/2
Nominal
*1.5
*2
*5
*10
*20
*30
*40
*50
*100
*200
*500
*1000

root(KL/v^3)
1123
794.0978
502.2316
355.1315
251.1164
224.6057
194.5149
158.8222
112.31
79.4312
50.308
35.7525
29.4342
25.7818
18.3715
17.2241
20.1039
23.5308
26.7159
29.6309
41.4505
58.4582
92.3589
130.6007
Line
slope
y-intercept
r-squared
8000

MATLAB

Change

Fitting Dispersion Time
Varying Dp
MATLAB (s) Approximation (s) Error
7333.5959
7249.5 -1%
5168.0614
5111.6357 -1%
3246.5162
3214.5054 -1%
2277.4571
2258.35475 -1%
1592.6579
1582.2566 -1%
1418.1205
1409.93705 -1%
1220.013
1214.34685 0%
985.025
982.3443 0%
680.3912
680.015 0%
465.709
466.3028 0%
274.8694
277.002 1%
181.3065
182.39125 1%
141.0439
141.3223 0%
117.8387
117.5817 0%
73.0282
69.41475 -5%
66.14
61.95665 -6%
83.3603
80.67535 -3%
103.9178
102.9502 -1%
123.928
123.65335 0%
142.3915
142.60085 0%
218.1099
219.42825 1%
328.3564
329.9783 0%
548.7221
550.33285 0%
801.0696
798.90455 0%
of best fit for highlighted data
6.47294151
-48.21067885
0.999913226

6000
4000
2000

0
0
500
1000
y = 6.5747x - 54.345
root(KL/v^3)
R² = 1

1500
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Data for the Vinciguerra number

/1000
/500
/200
/100
/50
/40
/30
/20
/10
/5
/2
Nominal
*1.5
*2
*5
*10
*20
*30
*40
*50
*100
*200
*500
*1000

MATLAB

Change

Fitting Dispersion Time
Varying R
root(KL/v^3) MATLAB (s) Approximation (s)
Error
0.0166
0.013884
-49.8921 -359450%
0.1311
0.020063
-49.14785 -245068%
1.0457
0.33116
-43.20295 -13146%
16.3269
60.9197
56.12485
-8%
130.6007
801.6732
798.90455
0%
440.7684
2841.864
2814.9946
-1%
1044.8
6818.4451
6741.2
-1%
16324 107414.894
106056
-1%
130600
859798
848850
-1%
Line of best fit for highlighted data
6.58374287
slope
-41.17147965
y-intercept
0.999999993
r-squared
1000000
800000
600000
400000
200000
0

0
y = 6.5839x - 57.029
R² = 1

50000

100000

root(KL/v^3)

150000
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Data for the Vinciguerra number

/1000
/500
/200
/100
/50
/40
/30
/20
/10
/5
/2
Nominal
*1.5
*2
*5
*10
*20
*30
*40
*50
*100
*200
*500
*1000

30000

MATLAB

Change

Fitting Dispersion Time
Varying L
root(KL/v^3) MATLAB (s) Approximation (s) Error
4.13
5.6983
-23.155 -506%
5.8406
10.5501
-12.0361 -214%
9.2349
24.1517
10.02685 -58%
13.0601
43.3256
34.89065 -19%
18.4697
74.1218
70.05305
-5%
20.6498
87.0355
84.2237
-3%
23.8443
106.7504
104.98795
-2%
29.2032
140.1012
139.8208
0%
41.2996
217.7352
218.4474
0%
58.4064
327.8266
329.6416
1%
92.3487
550.5992
550.26655
0%
130.6007
801.6732
798.90455
0%
159.9526
993.0704
989.6919
0%
184.6973
1158.8906
1150.53245
-1%
292.0321
1862.636
1848.20865
-1%
412.9958
2659.0186
2634.4727
-1%
584.0642
3785.2736
3746.4173
-1%
715.3296
4639.3733
4599.6424
-1%
825.9915
5378.0388
5318.94475
-1%
923.4866
6019.9124
5952.6629
-1%
1306
8538.2952
8439
-1%
1847 12099.8264
11955.5
-1%
2920.3 19166.3746
18931.95
-1%
4130 27130.2003
26795
-1%
Line of best fit for highlighted data
6.571225023
slope
-55.80755791
y-intercept
0.999997394
r-squared

20000

10000
0

0
1000
y = 6.5819x - 56.31
R² = 1

2000

3000

root(KL/v^3)

4000

5000
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Data for the Vinciguerra number
Fitting Time to Steady-State in Probe
Data
V
V (m3/s) COMSOL (s)
1.67E-14
8.35E-13
252
1.67E-12
193
3.34E-12
121
3.71E-12
112
4.18E-12
103
4.77E-12
93
5.57E-12
84
6.68E-12
74
8.35E-12
64
1.11E-11
53
1.67E-11
42
2.51E-11
34
3.34E-11
30
8.35E-11
18
1.67E-10
10

L
L (m)
0.010
0.004
0.003
0.002
0.001

100
COMSOL

COMSOL

300

COMSOL (s) Change
90
/30
50
/20
42
/10
34
/5
24
/2
Nominal
*1.5
*2
*5
*10
*20
*30
*40
*50
*100
*200
*500
*1000

200
100

D
D (m2/s)
2.54E-12
3.81E-12
7.62E-12
1.52E-11
3.81E-11
7.62E-11
1.14E-10
1.52E-10
3.81E-10
7.62E-10
1.52E-09
2.29E-09
3.05E-09
3.81E-09
7.62E-09
1.52E-08
3.81E-08
7.62E-08

COMSOL (s)
52
56
51
45
42
41
40
39
38
38
38
38
38
37
37
37
36

60
COMSOL

Change
/50
/20
/10
/5
/4.5
/4
/3.5
/3
/2.5
/2
/1.5
Nominal
*1.5
*2
*5
*10

50

40
20

0
0.00E+00 1.00E-10 2.00E-10

0
0.000 0.010 0.020

0
0.00E+005.00E-11 1.00E-10 1.50E-10

V (m3/s)

L (m)

D (m2/s)
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Data for the Vinciguerra number
Multilinear Regression
All three parameters (L, vz , D) and assessed individually
Real Time
COMSOL (s)
252
193
121
112
103
93
84
V
74
64
53
42
34
30
18
10
90
50
L
34
24
56
51
45
41
40
39
38
D
38
38
38
38
37
37
37
36

Data from above
L (m)
D (m2/s)
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.003
7.62E-11
0.01
7.62E-11
0.004
7.62E-11
0.002
7.62E-11
0.001
7.62E-11
0.003
7.62E-12
0.003
1.524E-11
0.003
3.81E-11
0.003
1.143E-10
0.003
1.524E-10
0.003
3.81E-10
0.003
7.62E-10
0.003
1.524E-09
0.003
2.286E-09
0.003
3.048E-09
0.003
3.81E-09
0.003
7.62E-09
0.003
1.524E-08
0.003
3.81E-08
0.003
7.62E-08

V (m 3/s)
8.35E-13
1.67E-12
3.34E-12
3.71111E-12
4.175E-12
4.77143E-12
5.56667E-12
6.68E-12
8.35E-12
1.11333E-11
1.67E-11
2.505E-11
3.34E-11
8.35E-11
1.67E-10
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11
1.67E-11

Processed for
1/root(vz )
L
327.3135068
0.003
231.4456002
0.003
163.6567534
0.003
155.2584286
0.003
146.3790502
0.003
136.9250636
0.003
126.7679761
0.003
115.7228001
0.003
103.505619
0.003
89.63849553
0.003
73.18952512
0.003
59.75899702
0.003
51.75280952
0.003
32.73135068
0.003
23.14456002
0.003
73.18952512
0.01
73.18952512
0.004
73.18952512
0.002
73.18952512
0.001
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003
73.18952512
0.003

MATLAB
Results
1/root(D) Constant Approximation (s) Deviation
114557.23
1
2.60E+02
3%
114557.23
1
1.78E+02
-8%
114557.23
1
1.21E+02
0%
114557.23
1
1.14E+02
2%
114557.23
1
1.06E+02
3%
114557.23
1
9.81E+01
5%
114557.23
1
8.95E+01
7%
114557.23
1
8.01E+01
8%
114557.23
1
6.97E+01
9%
114557.23
1
5.79E+01
9%
114557.23
1
4.39E+01
5%
114557.23
1
3.25E+01
-4%
114557.23
1
2.57E+01
-14%
114557.23
1
9.55E+00
-47%
114557.23
1
1.40E+00
-86%
114557.23
1
9.29E+01
3%
114557.23
1
5.09E+01
2%
114557.23
1
3.69E+01
9%
114557.23
1
2.99E+01
25%
362261.78
1
5.63E+01
1%
256157.76
1
5.10E+01
0%
162008.39
1
4.63E+01
3%
93535.59
1
4.29E+01
5%
81004.20
1
4.23E+01
6%
51231.55
1
4.08E+01
5%
36226.18
1
4.00E+01
5%
25615.78
1
3.95E+01
4%
20915.19
1
3.93E+01
3%
18113.09
1
3.91E+01
3%
16200.84
1
3.90E+01
3%
11455.72
1
3.88E+01
5%
8100.42
1
3.86E+01
4%
5123.16
1
3.85E+01
4%
3622.62
1
3.84E+01
7%

Equation to approximate time to steady-state in the probe

tsteady-state = 0.8379/sqrt(vz) + 6949.1*L + 5.5867e-5/sqrt(D) - 45.4092
This rounded version works just as well

tsteady-state = 0.85/sqrt(vz) + 7000*L + 5e-5/sqrt(D) - 45
Fit is good for steady-state times greater than 30 s

